WO2019050222A1 - Method for simply and efficiently isolating and purifying chemically labeled oligonucleotides by means of ph control - Google Patents

Method for simply and efficiently isolating and purifying chemically labeled oligonucleotides by means of ph control Download PDF

Info

Publication number
WO2019050222A1
WO2019050222A1 PCT/KR2018/010153 KR2018010153W WO2019050222A1 WO 2019050222 A1 WO2019050222 A1 WO 2019050222A1 KR 2018010153 W KR2018010153 W KR 2018010153W WO 2019050222 A1 WO2019050222 A1 WO 2019050222A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
container
aqueous solution
organic solvent
chemical marker
Prior art date
Application number
PCT/KR2018/010153
Other languages
French (fr)
Korean (ko)
Inventor
박소영
황지희
김성근
김영규
임순규
Original Assignee
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교산학협력단 filed Critical 서울대학교산학협력단
Publication of WO2019050222A1 publication Critical patent/WO2019050222A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Definitions

  • the present invention relates to a simple and efficient separation and purification method of chemically-labeled oligonucleic acid by pH control, and more particularly, to a method for efficiently and efficiently separating and purifying a labeled nucleic acid by using a change in distribution constant of a chemical marker according to pH control of a reaction solution And a kit using the same.
  • Nucleic acid is crucial to life as a carrier or messenger of genetic information. Since their discovery by F. Miescher, they have been able to elucidate their function, structure and mechanism of action by stimulating a widespread scientific interest.
  • molecular diagnostics is a field of in vitro diagnostics that detects or measures biomarkers such as DNA, RNA, and proteins using molecular biological techniques.
  • molecular diagnostics is a DNA or RNA Is used in the same sense as nucleic acid diagnostics for analyzing and detecting nucleic acid.
  • a labeled nucleic acid in which a fluorescent substance or a biochemical probe is bound has been the subject of interest.
  • a labeled nucleic acid is prepared by reacting a nucleic acid having a nucleophilic functional group such as a primary amine group or a thiol group with a marker such as a fluorescent dye or a probe, which is functionalized with an electrophilic functional group, and analyzing the labeled nucleic acid
  • a nucleophilic functional group such as a primary amine group or a thiol group
  • a marker such as a fluorescent dye or a probe
  • a fluorescent dye comprising an amine-reactive functional group capable of reacting with a primary amine group such as ester, isothiocyanate, aldehyde, etc.
  • Chemically react to form a labeled nucleic acid and the labeled nucleic acid is required to be separated and purified from unreacted dye and unreacted nucleic acid.
  • the marker in order to increase the yield of the labeled nucleic acid obtained through the reaction of the marker and the nucleic acid, the marker is used in excess relative to the nucleic acid. Therefore, untagged unreacted nucleic acids are present in trace amounts or almost not exist in the labeling reaction solution of nucleic acid, and unreacted markers are present in excess. A method of separating and purifying these excess unreacted markers from the labeled nucleic acid is indispensable.
  • Japanese Unexamined Patent Publication (Kokai) No. 2003-511046 discloses a method in which a plurality of dye-labeled polynucleotides and dye-labeled molecules (undetected dye-labeled molecules) not attached to the polynucleotide Is contacted with a plurality of particles comprising a hydrophilic crosslinked tertiary polymer matrix containing therein a hydrophobic porous adsorbent material capable of adsorbing undetected dye label molecules, and the undetected dye label molecules are immobilized on a hydrophilic matrix To the hydrophobic substance, and the dye-labeled polynucleotide does not pass through the hydrophilic matrix due to its size, thereby removing undetected dye-labeled molecules from the mixture.
  • the method has disadvantages such as inconvenience in separation process and long time, especially separation purification time is long, and the technology for separation and purification of the nucleic acid variant developed so far is difficult to apply to a large-scale process There is a problem.
  • JP-A-10-1446316 regarding the high-efficiency separation and purification of chemically-labeled nucleic acids, the hydrophobicity of the marker and the hydrophilic nature of the nucleic acid cause unreacted markers and labeled nucleic acids to have different solubilities in water and organic solvents
  • a method capable of separating and purifying a labeled nucleic acid from a mixture containing an unreacted marker and a labeled nucleic acid with high efficiency by using the property of the labeled nucleic acid Although the method of separating and removing the unreacted hydrophobic marker into the organic solvent phase by using the difference in solubility in the solvent is used, this method has a limitation that the marker should exhibit the hydrophobic property.
  • the present invention is a simple and efficient method for efficiently separating and purifying only the labeled nucleic acid from a mixture containing a chemical marker and a nucleic acid capable of reacting with the chemical marker and a nucleic acid labeled with a non-reactant, And provides a method that can be used universally.
  • the present invention also relates to a kit that can be used for the separation and purification of labeled nucleic acids using the above separation and purification method.
  • the present invention provides a method for preparing a nucleic acid comprising the steps of: a) preparing a reaction solution by reacting a chemical marker and a nucleic acid capable of reacting with the chemical marker in an aqueous solution; b) adjusting the pH of the reaction solution to within a predetermined range; c) adding an organic solvent separated into the aqueous solution layer and the organic solvent layer to the pH-adjusted reaction solution, and stirring to prepare a mixed solution; And d) removing at least a portion of the organic solvent.
  • the organic solvent added in the step c) may include water (H2O).
  • the organic solvent may be an organic solvent in which water (H20) is saturated.
  • the pH of the predetermined reaction solution may be in a range lower than the pKa of the chemical marker, and in this case, the step b) may be carried out by mixing the aqueous solution adjusted to pH lower than the chemical marker pKa, By mixing the solution, the pH of the mixed reaction solution can be adjusted within a predetermined range.
  • e) further comprises performing the steps b) to d) one or more times.
  • the chemical marker may be a hydrophobic fluorescent dye or a hydrophilic fluorescent dye.
  • the nucleic acid may be an oligonucleotide.
  • the chemical marker may be at least one selected from Alexa 488, Cy 5, ATTO 633, Cy 3, Cy 3B, ATTO 550, ATTO 390, ATTO 647N, Rhodamine 6G and Nile red.
  • the organic solvent may be an organic solvent having a log P value of 0.6 to 4.0.
  • the organic solvent is selected from the group consisting of alcohols having 3 to 8 carbon atoms, ether having 3 to 8 carbon atoms, chloroform, alkyl acetates having 2 to 6 carbon atoms, aromatic hydrocarbons having 6 to 12 carbon atoms, linear or branched An alkane, a cycloalkane having 5 to 14 carbon atoms, a linear or branched alkyl group having 5 to 12 carbon atoms, a hydrocarbon having a cycloalkyl group having 5 to 12 carbon atoms, a 1,1,1-trichloroethane or a mixture thereof Lt; / RTI >
  • it may include centrifuging the mixed solution between steps c) and d).
  • a method of detecting a nucleic acid comprising the steps of: (a) providing a first container containing a chemical marker capable of reacting with a nucleic acid and capable of reacting with the nucleic acid; A third container containing an acidic aqueous solution having a predetermined pH value; And a fourth container containing an organic solvent containing at least a part of water (H2O), wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid, Wherein the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker.
  • the present invention provides a pharmaceutical composition
  • a pharmaceutical composition comprising a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; Wherein the pH of the acidic aqueous solution in the third container is such that the chemical markers in the first container are in contact with the nucleic acid in the second container, Wherein the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the reaction is set to be lower than the pKa of the chemical markers.
  • the present invention also relates to a pharmaceutical composition
  • a pharmaceutical composition comprising a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; And an organic solvent containing at least a part of water (H2O); Wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid in the second container, Wherein the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker.
  • the organic solvent in the kit for separating and purifying the labeled nucleic acid according to the present invention may contain water in a saturated state.
  • the kit for separation and purification of the labeled nucleic acid may further comprise a container containing a basic aqueous solution for adjusting the pH of the acidic aqueous solution of the third container after the chemical marker and the nucleic acid are reacted, , And a separation device capable of separating the organic solvent and the aqueous solution.
  • the neutral state of the marker used for labeling is induced by controlling the pH of the reaction mixture aqueous solution according to the reaction between the nucleic acid and the chemical marker irrespective of the hydrophilic and hydrophobic properties of the fluorescent substance (Dye) used as a chemical marker
  • Dye fluorescent substance
  • FIG. 7 is a conceptual diagram illustrating a method for removing unreacted dyes from a reaction with a nucleic acid and a chemical marker for preparing labeled oligonucleic acid through pH control of an aqueous solution according to the present invention.
  • FIG. 3 is a graph showing the relationship between the amount of nucleic acid (DNA) and the amount of nucleic acid (nucleic acid) added to the lower aqueous solution layer and the upper organic solvent layer under constant PH conditions according to Examples (Examples 1, 2, ) And the degree of distribution of the fluorescent dye.
  • FIG. 5 is a graph showing the relationship between the concentration of the mixture (Cy (1)) in the aqueous solution separated and purified by the conventional ethanol recrystallization method (upper graph in FIG. 5) and the solvent extraction method 5 and DNA) were separated by liquid chromatography (HPLC), respectively.
  • FIG. 6A is a graph showing the relationship between the amount of the aqueous solution separated and purified by the ethanol recrystallization method (upper left graph in FIG. 6) and the solvent extraction method using the pH control according to the first embodiment (upper right graph in FIG. 6) (Cy5 and dsDNA) were obtained through confocal microscopy.
  • FIG. 6B is a graph showing the relationship between the amount of the aqueous solution separated and purified by the ethanol recrystallization method (lower left graph in FIG. 6) and the solvent extraction method using the pH control according to Example 1 (lower right graph in FIG. 6) (Cy 5 and dsDNA) on the photoreceptor of the present invention.
  • FIG. 7A is a graph showing the absorbance of Cy3B remaining in the aqueous solution according to the pH condition after the unreacted Cy3B fluorescent dye is separated using the pH controlled separation and purification method according to Example 4 of the present invention.
  • FIG. 7A is a graph showing the absorbance of Cy3B remaining in the aqueous solution according to the pH condition after the unreacted Cy3B fluorescent dye is separated using the pH controlled separation and purification method according to Example 4 of the present invention.
  • a method of separating and purifying a chemically-labeled nucleic acid comprises the steps of: a) preparing a reaction solution by reacting a chemical marker and a nucleic acid capable of reacting with the chemical marker in an aqueous solution; b) adjusting the pH of the reaction solution to within a predetermined range; c) adding an organic solvent separated into the aqueous solution layer and the organic solvent layer to the pH-adjusted reaction solution, and stirring to prepare a mixed solution; And d) removing at least a portion of the organic solvent.
  • step (a) of the present invention the labeling reaction of the chemical marker and the nucleic acid capable of reacting with the chemical marker can be carried out under standard conditions generally known in aqueous solution.
  • reaction time and the reaction temperature are not limited to a specific range.
  • the reaction may be performed in the range of 0 to 50 degrees for 5 minutes to 12 hours. For example, For 2 to 3 hours.
  • the chemical marker is excessively more than the number of moles of the nucleic acid in that it minimizes the unreacted nucleic acid after the reaction.
  • the chemical marker is at least 1 time, preferably at least 2 times, more preferably at least 5 times, More preferably 10 times or more, and it is preferably 5 times or more in view of the cost of the chemical marker and the subsequent purification process.
  • the chemical markers used in the present invention are used as markers for the detection of nucleic acids in the art and include optical sensing materials that can be detected through ultraviolet, infrared or visible light, or can be detected through a change in refractive index, Or electrically detectable material, and typically a fluorescent dye can be used.
  • the fluorescent dyes may be generally divided into hydrophilic fluorescent dyes and hydrophobic fluorescent dyes. All of these hydrophilic fluorescent dyes or hydrophobic fluorescent dyes are substituted with a substituent which is removed when reacting with the nucleophile of the nucleic acid so as to easily react with the nucleic acid. And a leaving group.
  • fluorescent dyes examples include Acridine homodimer and derivatives thereof, Acridine Orange and derivatives thereof, 7-aminoactinomycin D , 7-AAD) and derivatives thereof, Actinomycin D and derivatives thereof, ACMA (9-amino-6-chloro-2-methoxyacridine and derivatives thereof, DAPI) Ethidium bromide and derivatives thereof, ethidium homodimer-1 (EthD-1) and derivatives thereof, ethidium homodimer-2 (EthD-2) and derivatives thereof, dihydroethidium and derivatives thereof, ethidium bromide and derivatives thereof, And derivatives thereof, Ethidium monoazide and derivatives thereof, Hexidium iodide and derivatives thereof, bisbenzimide (Hoechst 33258) and derivatives thereof, Hoechst 33342 ) And its oil Hydroxystilbamidine and derivatives thereof, LDS 751 and derivatives thereof, Propidium I
  • labeling using a fluorescent chromophore dye is preferred as the chemical marker, but it is apparent that other forms of detectable labeling are also available to those skilled in the art.
  • microparticles, gold nanoparticles (Reichert et al., Anal. Chem. 72: 6025-6029, 2000) and microbeads (Lacoste et al. , Proc. Natl. Acad. Sci. USA 97 (17): 9461-9466, 2000) can be used either as negative chargeable ligands or as positively charged ligands, so that surface charge control at non- .
  • a nucleic acid capable of reacting with a chemical marker in the present invention is a water-soluble polymer including a sugar, a phosphoric acid and a base, and it means DNA or RNA or a mixture thereof.
  • the oligonucleotide means that the number of nucleotides is 100 or less or 50 or less.
  • step a) of the present invention the nucleic acid is pre-treated so as to bind to a chemical marker, which is obtained by introducing a functional group capable of reacting with a chemical marker into the nucleic acid, or by commercially purchasing a nucleic acid already having a functional group introduced thereto .
  • a nucleic acid having a nucleophilic functional group such as a primary amine group or a thiol group is reacted with a marker such as a fluorescent dye or a probe functionalized with an electrophilic functional group to produce a labeled nucleic acid
  • a marker such as a fluorescent dye or a probe functionalized with an electrophilic functional group
  • the kind of the functional group present or newly attached to the nucleic acid is not limited.
  • the nucleophilic functional group includes a primary amine group or a thiol group.
  • the chemical marker is an ester, isothiocyanate, isocyanate, acyl azide, NHS ester , Sulfonyl chloride, aldehyde, and the like.
  • the label may include functional groups such as haloacetyl, alkyl halide derivatives, maleimide, aziridine, etc., A primary amine group may be preferably used.
  • the method for producing a nucleic acid capable of binding to a chemical marker by attaching such a functional group to a nucleic acid can be carried out by a conventional method in the art besides the above exemplified method.
  • the step b) of the present invention is a step of adjusting the pH of the reaction solution obtained by the reaction of the chemical marker with the nucleic acid to a predetermined range, thereby changing the ionization state of the chemical marker,
  • the organic layer and the aqueous solution layer are separated from each other by mixing the organic solvent in c)
  • the unreacted chemical markers can be effectively removed according to the difference in solubility between the aqueous solution and the organic solvent. do.
  • the pH range of the reaction solution usually used in the present invention may be in the range of pH 1 to pH 10, preferably in the range of pH 1 to pH 7, more preferably in the range of pH 2 to pH 5 .
  • the pH of the predetermined reaction solution is maintained in a range lower than the pKa of the chemical marker.
  • a substance which is weakly acidic in aqueous solution and which is dissociated into an anion portion of a chemical marker and a proton (H + ) can be used, wherein the marker has a neutral and anionic concentration
  • the concentration of the ionic chemical markers having a negative charge becomes higher than that of the neutral markers
  • the ionic indicator becomes more soluble in the aqueous solution, and therefore, the unreacted marker can not be extracted and separated into the organic solvent layer in an aqueous solution of pH higher than the pKa value of the chemical marker.
  • an unreacted neutral chemical marker is extracted and separated into an organic solvent layer by mixing a certain amount of an organic solvent with an aqueous solution of the mixture containing a nucleic acid and an unreacted chemical marker and then inducing the layer separation It is possible to remove unreacted chemical markers more efficiently and easily.
  • an acidic solution having a predetermined concentration may be used.
  • HNO 3, HClO 4, H 2 SO 4, HCl, HBr, HI and the like, which are classified as strong acids, have.
  • aqueous solution acid in small quantities under a condition of a large amount of aqueous solution through a mechanism such as a pipette.
  • the pH of the mixed reaction solution can be adjusted to a predetermined range by mixing the reaction solution with an aqueous solution adjusted to pH lower than the pKa of the chemical marker, An acidic solution can be used to prepare an aqueous solution adjusted to a pH lower than the pKa.
  • the stirring method for adding the reaction solution to the aqueous solution adjusted to a pH lower than the pKa of the chemical marker and for increasing the mixing time and the mixing efficiency when mixing is not limited and it is also possible to use a stirring device such as simple stirring or shaking or using a vortex mixer .
  • the pH condition of the present invention may be adjusted by using a commercially available pH meter or using a pH test paper having a measurement range of 1 to 14 .
  • pH 1.8 to 9.0 under ultraviolet / visible ray spectroscopy 1 where the absorbance of the fluorescent dye is 1/2
  • the acid dissociation constant (pKa) is dependent on the temperature dependence when the dissociation reaction of the acid is an exothermic reaction and the endothermic reaction. Specifically, when the dissociation reaction is an endothermic reaction, the pKa value decreases as the temperature increases, and when the dissociation reaction occurs as an exothermic reaction, the pKa value increases as the temperature increases.
  • an organic solvent separated into an aqueous solution layer and an organic solvent layer is added to a reaction solution whose pH is controlled, and stirred to prepare a mixed solution.
  • the amount of the organic solvent is not limited, it is preferable that the volume of the organic solvent is excessively larger than the volume of the mixed aqueous solution of the step b) in order to remove the unreacted markers earlier and shorten the purification time by reducing the number of purification.
  • the organic solvent may be added at a volume of at least 2 times, at least 3 times, at least 5 times, or at least 10 times.
  • the organic solvent used in step c) may include water (H2O) in the organic solvent, and preferably the organic solvent is an organic solvent in which water (H2O) is saturated desirable.
  • the "organic solvent saturated with water” refers to an organic solvent in which the organic solvent dissolves as much as possible to dissolve the water so that the dissolution rate has reached equilibrium without further dissolving the water.
  • distilled water can be preferably used to minimize the incidental effect of the water used to saturate the organic solvent.
  • step c When the organic solvent is added in step c), the organic solvent is added in excess of the volume of the mixed aqueous solution in step b). Therefore, when water is not contained in the organic solvent, It is disadvantageous that the water layer containing the chemically labeled nucleic acid and the organic solvent layer containing the unreacted label may not be separated from each other or the aqueous solution layer may be difficult to be separated or separated.
  • the stirring time in the step c) is not limited, and may range from several seconds to several hours. Most of the time is sufficient for several seconds to several minutes, and the stirring method thereof is also not limited, Shaking, or using a device such as a vortex mixer.
  • the present invention utilizes the difference in solubility between water and an organic solvent of a chemical marker at a preset pH, and it is an object of the present invention to provide an organic solvent having a distribution coefficient of chemical markers of 2 or more at a pH range Can be preferably used.
  • the partition coefficient can be obtained by measuring the concentration of a chemical marker in an organic solvent and the concentration of a chemical marker in water via a UV / Vis spectrometer (sptectrometer).
  • the partition coefficient is an index showing the solubility of a solvent in water and an organic solvent.
  • a correlation between a chemical marker used for separation and purification of a chemically labeled nucleic acid and an organic solvent, The kind of the chemical marker and the organic solvent are not limited.
  • the chemical markers in the neutral state have a partition coefficient of 2 or more, preferably 10 or more, more preferably 25 or more, still more preferably 50 or more, still more preferably 100 or more, , More preferably 200 or more, and more preferably 300 or more.
  • the larger the partition coefficient the easier separation of the labeled nucleic acid from the unreacted marker.
  • FIG. 3 shows the distribution of fluorescent dyes between the nucleic acid layer and the aqueous solution layer and hexane as the organic solvent, The distribution of the fluorescent dye to the organic solvent layer is increased under the low pH condition.
  • the organic solvent used in the present invention is not particularly limited as long as it is an organic solvent from which water and a layer can be separated and in which an aqueous solution layer and an organic solvent layer can be separated.
  • an organic solvent having a log P value of 0.6 or more may be used in the present invention.
  • the log P value means the log value of P, which means the partition coefficient of the organic solvent for the same molar mixture of octanol and water.
  • the upper limit of the log P value of the organic solvent is not limited, but if the log P value is too high, the chemical markers of the neutral state may be dissolved in the water rather well, so that the chemical markers of neutral state and the organic solvent 2 is satisfied, it is possible to select an appropriate organic solvent.
  • Organic solvents which can be preferably used in relation to chemical markers in general neutral state are organic solvents having a log P value in the range of 0.6 to 4.0, more preferably organic solvents having a log P value in the range of 0.6 to 3.5, More preferably, it is an organic solvent having a log P value in the range of 0.6 to 3.0.
  • organic solvents having a log P value of 0.6 to 4.0 examples include alcohols having 3 to 8 carbon atoms, ethers having 3 to 8 carbon atoms, chloroform, alkyl acetates having 2 to 6 carbon atoms, aromatic hydrocarbons having 6 to 12 carbon atoms, A linear or branched alkane having 1 to 14 carbon atoms, a cycloalkane having 5 to 14 carbon atoms, a linear or branched alkyl group having 5 to 12 carbon atoms and a cycloalkyl group having 5 to 12 carbon atoms, 1,1,1-trichloroethane 1-butanol, isoamyl alcohol and pentanol; alcohols having 4 to 8 carbon atoms, such as ethyl acetate, diethyl ether, diisopropyl ether, butyl acetate, chloroform, Benzene, 1,1,1-trichloroethane, toluene, hexene
  • Step d) of the last step in the present invention is a step of removing at least a part of the organic solvent, at least partially removing an organic solvent mainly comprising unreacted chemical markers, preferably in a layered organic layer
  • Most organic solvents can be removed.
  • a method for removing the organic solvent a commonly used method can be used. In the continuous process, a decanter is used. In the batch process, a separating funnel or the like can be used. When the amount is small, Can be removed.
  • step of centrifuging the mixed solution is further included between the step c) and the step d), it may be advantageous in terms of shortening the purification time and increasing the purification yield.
  • the centrifugation method is not particularly limited, and can be performed by setting appropriate centrifugation conditions using a centrifuge.
  • 500 g, 1000 g, 2000 g, 4000 g or 6000 g and the centrifugation time can be 10 seconds, 20 seconds, 30 seconds, or about 1 minute, Phase separation occurs in a short time depending on the difference in density of the mixed aqueous solution and the organic solvent, and the organic solvent can be removed more efficiently in the step d).
  • the step of removing the unreacted nucleic acid may be further performed before the step b) or after the step d).
  • the step of removing the unreacted nucleic acid remaining in the aqueous solution layer is almost meaningless since the reaction efficiency between the nucleic acid and the marker is considerably high.
  • the reaction efficiency between the nucleic acid and the marker is considerably high, and the step of further removing the unreacted nucleic acid remaining in the aqueous solution layer is almost meaningless
  • the reaction efficiency between the nucleic acid and the marker is not high, in order to selectively purify only the labeled nucleic acid, the unreacted nucleic acid remaining in the aqueous solution layer is further removed
  • the method of removing such unreacted nucleic acid in the present invention can be carried out according to a known method.
  • unreacted nucleic acid can be removed by chromatography such as reversed phase and ion exchange, or gel electrophoresis. Since the nucleic acid labeled with a hydrophobic marker is partially hydrophobic, the hydrophilic nature of the unreacted nucleic acid And thus simpler purification is possible. Thus, the labeled nucleic acid and the unreacted nucleic acid can be separated from each other by HPLC reverse phase chromatography, and can be purified using a disposable reversed phase column (Polypak, Glen Research, Inc., USA).
  • the present invention relates to a method of separating and purifying a chemically labeled nucleic acid according to the present invention in a temporal order, and more particularly, to a method for producing a labeled nucleic acid A method for removing unreacted dyes from a reaction between a marker and nucleic acid is exemplarily shown.
  • the method for separating and purifying nucleic acid comprises the steps of adding a pH-adjusted aqueous solution to a labeled nucleic acid reaction solution, and then adding 2 to 4
  • stirring was performed using a vortex mixer for 10 seconds or more, and then a butanol solution in which an unreacted marker located at the upper part was dispersed was removed by using a micropipette or the like, It is schematically shown that an aqueous solution in which a highly purified labeled nucleic acid is dispersed can be obtained.
  • the present invention can provide a kit for a method for separating and purifying a chemically-labeled nucleic acid using the above method.
  • the kit includes a chemical label capable of reacting with a nucleic acid, and a first container in which, when a nucleic acid containing an aqueous solution is introduced, the nucleic acid and the chemical marker can react with each other;
  • a third container containing an acidic aqueous solution having a predetermined pH value;
  • a fourth container containing an organic solvent containing at least a part of water (H2O), wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid, And the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker.
  • the kit may be prepared such that after the nucleic acid and the chemical marker react in the first container, the acidic aqueous solution is added to the third container, the pH is adjusted, and then the organic solvent in the fourth container is introduced, The nucleic acid can be purified.
  • the kit comprises a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; Wherein the pH of the acidic aqueous solution in the third container is such that the chemical markers in the first container are in contact with the nucleic acid in the second container, The pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the reaction is set to be lower than the pKa of the chemical marker.
  • the kit may be prepared such that after the nucleic acid and the chemical marker react in the second container, the acidic aqueous solution is added to the third container, the pH is adjusted, and then the organic solvent in the fourth container is introduced, The nucleic acid can be purified.
  • the kit comprises a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; And an organic solvent containing at least a part of water (H2O); Wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid in the second container, And the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker.
  • the kit can be prepared by reacting a chemical marker in the first container with a nucleic acid in the fifth container in a second container, and then introducing an acidic aqueous solution in the third container to adjust the pH,
  • the labeled nucleic acid can be purified.
  • the kit for separating and purifying the labeled nucleic acid according to the present invention may further comprise a container containing a basic aqueous solution for adjusting the pH in mixing the acidic aqueous solution of the third container with the nucleic acid after the chemical label is reacted with the nucleic acid, .
  • the kit may further include a separation device capable of separating the organic solvent and the aqueous solution, and a separating funnel, a pipette, a centrifuge, etc. may be used as an exemplary separation device.
  • a kit for separating and purifying a labeled nucleic acid according to the present invention is a device for actually applying a method for separation and purification of a labeled nucleic acid as described in detail above, wherein the materials of the first to fourth containers are metal, glass, rubber, Materials and the like can be used, but the present invention is not limited thereto, and the size thereof can be variously modified in accordance with the content of the organic solvent and the nucleic acid to be used, and can be appropriately changed by a person skilled in the art.
  • a modified oligo nucleic acid (DNA 30 mer / 60mer) having an amine group and a fluorescent dye Cy 5 (Cy5 NHS ester # PA 15104) in a 2 ml tube were reacted at a molar ratio of 1:10 and maintained at room temperature for 2 to 3 hours .
  • the sequence of the modified oligonucleotide (DNA 30 mer, 60mer) is shown in Table 1 below.
  • a modified oligo nucleic acid (DNA 30 mer / 60mer) having an amine group in a 2 ml tube was reacted with a fluorescent dye Cy 5 at a reaction ratio of 1:10 and maintained at room temperature for 2 to 3 hours.
  • Fig. 3 is a graph showing the relationship between the amount of the nucleic acid and the fluorescence (fluorescence) of the organic solvent layer on the lower aqueous solution layer and the upper organic solvent layer under constant PH conditions according to the examples (Examples 1, 2 and 3)
  • A Cy5 (Comparative Example 1 on the left, Example 1 on the right),
  • B Cy3 (Comparative Example 2 on the left, Comparative Example 2 on the right), Cy3 (Example 2),
  • C) Alexa 488 Comparative Example 3 on the left, and Example 3 on the right).
  • FIG. 5 is a graph showing the result of separation and purification of a mixture in an aqueous solution obtained by the ethanol recrystallization method and the separation and purification method of the present invention through liquid chromatography (HPCL). More specifically, the upper graph of FIG. (Cy 5 and DNA) in aqueous solution separated and purified according to the ethanol recrystallization method according to the present invention were separated by liquid chromatography (HPLC), respectively. In the lower graph of FIG. 5, And the result of solvent extraction using pH control according to the present invention.
  • the unreacted fluorescent dye Cy 5 was detected between 10 and 13 minutes in the case of the mixture purified by the ethanol recrystallization method, whereas in the case of the extraction method using pH control according to the present invention, unreacted fluorescent dye Cy 5 was not detected, indicating that the separation and purification method of the present invention is a highly efficient separation and purification method as compared with the conventional ethanol recrystallization method.
  • FIG. 6 shows the results of testing the fluorescent performance of the ethanol recrystallization method according to the prior art and the labeled nucleic acid isolated and purified according to the present invention.
  • FIG. 6A shows the ssDNA labeled with a fluorescent dye, Cy5, together with a complementary chain, followed by confocal microscopy.
  • 6) and the mixture (Cy5 and dsDNA) in the aqueous solution separated and purified by the solvent extraction method using the pH control according to Example 1 according to the present invention were examined with a confocal microscope confocal microscopy. It can be seen that there is no difference in fluorescence performance between the ethanol recrystallization method and the two samples purified by the present invention, and thus the purification method according to the present invention can be usefully used. .
  • FIG. 6B is a graph showing the results of separation and purification by the ethanol recrystallization method (lower left graph in FIG. 6) and the solvent extraction method using pH control according to Example 1 (lower right graph in FIG. 6) (Cy 5 and dsDNA) in the aqueous solution, the number of photons per pixel and the maximum number of photons were measured.
  • the number of photons per pixel and the maximum number of photons were measured. It can be confirmed that there is no difference in the two samples purified by the present invention.
  • the fluorescence performance of the labeled nucleic acid isolated and purified through the present invention can be maintained and applied to various types of labels.
  • the simple and efficient separation and purification method of chemically labeled oligonucleic acid by pH control according to the present invention can separate and purify the labeled nucleic acid easily and efficiently with various kinds of unreacted markers regardless of the type of the marker, It is easy to manufacture a kit using the same, which is highly likely to be used in industry.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method for simply and efficiently isolating and purifying chemically labeled oligonucleotides by means of pH control and, more specifically, to a method and a kit for efficiently isolating and purifying labeled nucleotides by using a change in the distribution constant of a chemical marker according to the pH control of a reaction solution.

Description

pH 제어에 의한 화학적으로 표지된 올리고 핵산의 간편하고 효율적인 분리정제법Simple and Efficient Separation and Purification of Chemically Labeled Oligonucleotides by pH Control
본 발명은 pH 제어에 의한 화학적으로 표지된 올리고 핵산의 간편하고 효율적인 분리정제법에 관한 것으로, 보다 상세하게는 반응용액의 pH 조절에 따른 화학적 표지자의 분배상수 변화를 이용하여 표지화된 핵산을 효율적으로 분리 정제하는 방법 및 이를 이용한 키트에 관한 것이다.The present invention relates to a simple and efficient separation and purification method of chemically-labeled oligonucleic acid by pH control, and more particularly, to a method for efficiently and efficiently separating and purifying a labeled nucleic acid by using a change in distribution constant of a chemical marker according to pH control of a reaction solution And a kit using the same.
핵산은 유전 정보의 운반자 또는 전달자로서 생명체에 있어 매우 중요하다. 미세르(F.Miescher)에 의해 발견된 이래로 이들은 광범위한 과학적 관심을 자극함으로써 그 기능, 구조 및 작용 메카니즘을 해명할 수 있게 되었다. Nucleic acid is crucial to life as a carrier or messenger of genetic information. Since their discovery by F. Miescher, they have been able to elucidate their function, structure and mechanism of action by stimulating a widespread scientific interest.
이러한 기본적인 분자 생물학적 메카니즘에 대한 지식이 증가함에 따라, 최근에는 유전자의 새로운 조합을 수행할 수 있게 되었고, 이러한 기술은 예컨대, 의학적 진단 및 치료, 그리고 식물 품종개량에 있어서 새로운 가능성을 열어 주고 있다.As knowledge of this basic molecular biological mechanism has increased, a new combination of genes has become available in recent years and this technology opens up new possibilities, for example, in medical diagnosis and treatment, and in plant breeding.
한편, 분자진단학(molecular diagnostics)은 분자생물학적 기술을 이용하여 DNA, RNA, 단백질 등의 생체지표 물질(biomarker)을 검출하거나 측정하는 체외진단학의 한 분야이며, 좁은 의미로서 유전정보 물질인 DNA 또는 RNA를 분석하고 검출하는 핵산진단학(nucleic acid diagnostics)과 같은 의미로 사용되고 있으며, 동 분야에서 형광물질 또는 생화학적 프로브가 결합된 표지화된 핵산이 주요한 관심의 연구 대상이 되어 왔다.On the other hand, molecular diagnostics is a field of in vitro diagnostics that detects or measures biomarkers such as DNA, RNA, and proteins using molecular biological techniques. In a narrow sense, molecular diagnostics is a DNA or RNA Is used in the same sense as nucleic acid diagnostics for analyzing and detecting nucleic acid. In this field, a labeled nucleic acid in which a fluorescent substance or a biochemical probe is bound has been the subject of interest.
이와 관련하여 1차 아민기 또는 티올기와 같은 친핵성 작용기를 갖는 핵산을 친전자성 작용기로 관능화된 형광 염료 또는 프로브 등과 같은 표지자와 반응시킴으로써 표지화된 핵산을 제조하고, 이러한 표지화된 핵산을 분석하는 다양한 방법이 공지되어 있다[Hermanson, G.T. Bioconjugate techniques; Academic Press, 2008.].In this connection, a labeled nucleic acid is prepared by reacting a nucleic acid having a nucleophilic functional group such as a primary amine group or a thiol group with a marker such as a fluorescent dye or a probe, which is functionalized with an electrophilic functional group, and analyzing the labeled nucleic acid A variety of methods are known [Hermanson, GT Bioconjugate techniques; Academic Press, 2008.].
예를 들어, 1차 아민기로 매개된 접합의 경우 에스테르, 이소티오시아네이트, 알데히드 등과 같이 1차 아민기와 반응할 수 있는 아민-반응성 작용기를 포함하는 형광염료가 핵산에 도입되어 있는 1차 아민기와 화학적으로 반응함으로써 표지화된 핵산을 형성하며, 이와 같이 표지화된 핵산은 미반응 염료 및 미반응 핵산으로부터 분리 정제하는 단계를 필요로 한다.For example, in the case of a primary amine-mediated conjugation, a fluorescent dye comprising an amine-reactive functional group capable of reacting with a primary amine group such as ester, isothiocyanate, aldehyde, etc., Chemically react to form a labeled nucleic acid, and the labeled nucleic acid is required to be separated and purified from unreacted dye and unreacted nucleic acid.
일반적으로, 표지자와 핵산의 반응을 통해 얻어지는 표지화된 핵산의 수율을 높이기 위해서, 표지자를 핵산에 비해 과량으로 사용한다. 따라서, 핵산의 표지화 반응 용액 중에서 표지화되지 않은 미반응 핵산은 미량으로 존재하거나 거의 존재하지 않으며, 미반응 표지자는 과량으로 존재하게 된다. 이러한 과량의 미반응 표지자를 표지화된 핵산으로부터 분리 정제하는 방법이 필수적으로 필요하다.Generally, in order to increase the yield of the labeled nucleic acid obtained through the reaction of the marker and the nucleic acid, the marker is used in excess relative to the nucleic acid. Therefore, untagged unreacted nucleic acids are present in trace amounts or almost not exist in the labeling reaction solution of nucleic acid, and unreacted markers are present in excess. A method of separating and purifying these excess unreacted markers from the labeled nucleic acid is indispensable.
이와 관련하여, 미반응 염료를 제거하는 종래의 방법으로는, 에탄올 침전법, 크기 제거 크로마토그래피(size-exclusion chromatography) 및 투석(dialysis) [Giusti, W.G.; Adriano, T. PCR methods and applications 1993, 2, 223]을 이용한 방법 등이 공지되어 있으나, 이러한 방법들은 대개 시간 소모적이고 불편하며 비효율적인 단점을 포함한다. In this regard, conventional methods of removing unreacted dyes include ethanol precipitation, size-exclusion chromatography, and dialysis (Giusti, W. G .; Adriano, T. PCR methods and applications 1993, 2, 223] have been known, but these methods generally involve time consuming, inconvenient and inefficient disadvantages.
예컨대, 크기 배제 크로마토그래피의 경우 30분 내지 1 시간 정도가 소요되며, 투석의 경우 수 시간이 소요되고, 전기 영동 겔 추출(extraction) 의 경우 하루 정도가 소요되는 것이 일반적이다.For example, it takes about 30 minutes to 1 hour for size exclusion chromatography, several hours for dialysis, and about one day for electrophoresis gel extraction.
한편, 표지화된 핵산의 분리 정제 방법과 관련된 종래의 기술로서, 일본 공개특허공보 제2003-511046호는 복수의 염료 표지 폴리 뉴클레오티드 및 폴리 뉴클레오티드에 부착되지 않은 염료 표지 분자(미검출 염료표지 분자)를 함유하는 혼합물을, 미검출 염료 표지 분자를 흡착시킬 수 있는 소수성의 다공성 흡착성 물질을 내부에 포함하는 친수성의 가교 3차 기초 고분자 매트릭스로 이루어지는 복수의 입자와 접촉시켜, 미검출 염료 표지 분자는 친수성 매트릭스를 통과하여 소수성 물질에 흡착되고, 염료 표지 폴리 뉴클레오티드는 그 사이즈로 인해 친수성 매트릭스를 통과하지 못하게 함으로써, 혼합물로부터 미 검출 염료 표지 분자를 제거하는 방법을 기재하고 있다.As a conventional technique related to the separation and purification method of labeled nucleic acid, Japanese Unexamined Patent Publication (Kokai) No. 2003-511046 discloses a method in which a plurality of dye-labeled polynucleotides and dye-labeled molecules (undetected dye-labeled molecules) not attached to the polynucleotide Is contacted with a plurality of particles comprising a hydrophilic crosslinked tertiary polymer matrix containing therein a hydrophobic porous adsorbent material capable of adsorbing undetected dye label molecules, and the undetected dye label molecules are immobilized on a hydrophilic matrix To the hydrophobic substance, and the dye-labeled polynucleotide does not pass through the hydrophilic matrix due to its size, thereby removing undetected dye-labeled molecules from the mixture.
하지만, 상기 방법은 분리 공정상의 불편함과 장시간 소요 등의 문제점이 있거나, 특히 분리 정제 시간이 장시간 소요된다는 문제점이 있었으며, 현재까지 개발된 핵산 변형체의 분리 정제 기술은 대단위 수준의 공정에 적용하기 어려운 문제점이 있다.However, the method has disadvantages such as inconvenience in separation process and long time, especially separation purification time is long, and the technology for separation and purification of the nucleic acid variant developed so far is difficult to apply to a large-scale process There is a problem.
또한, 등록특허공보 10-1446316호에서는 화학적으로 표지된 핵산의 고효율 분리정제법에 관하여, 표지자의 소수성과 핵산의 친수성으로 인해 미반응 표지자와 표지화된 핵산이 물과 유기용매에 대한 상이한 용해도를 갖는 성질을 이용하여, 미반응 표지자 및 표지화된 핵산을 포함하는 혼합물로부터 표지화된 핵산을 고효율로 분리 정제할 수 있는 방법을 기재하고 있고, 이는 과량의 미반응의 표지자의 소수성 성질에 따른 수용액상과 유기용매상에서 각각의 용해도 차이를 이용하여 미반응의 소수성 표지자를 유기용매상으로 분리 제거하는 방식을 사용하고 있으나, 이러한 방법은 표지자가 소수성 성질을 띄어야 한다는 제한점이 존재하였다. In addition, in JP-A-10-1446316, regarding the high-efficiency separation and purification of chemically-labeled nucleic acids, the hydrophobicity of the marker and the hydrophilic nature of the nucleic acid cause unreacted markers and labeled nucleic acids to have different solubilities in water and organic solvents Discloses a method capable of separating and purifying a labeled nucleic acid from a mixture containing an unreacted marker and a labeled nucleic acid with high efficiency by using the property of the labeled nucleic acid, Although the method of separating and removing the unreacted hydrophobic marker into the organic solvent phase by using the difference in solubility in the solvent is used, this method has a limitation that the marker should exhibit the hydrophobic property.
따라서 표지자의 친수성 또는 소수성 성질에 상관없이 표지자가 가지는 고유의 특성에 따라 미반응의 표지자를 보다 효율적으로 분리 제거할 수 있는 방법 및 이를 이용한 키트에 관한 기술 개발의 필요성은 지속적으로 요구되고 있는 실정이다.Therefore, there is a continuing need to develop a technique for separating and removing unreacted markers more efficiently according to the inherent characteristics of the markers regardless of the hydrophilic or hydrophobic properties of the markers, and a kit using the same .
본 발명은 화학적 표지자 및 상기 화학적 표지자와 반응가능한 핵산의 반응에 의해 표지화된 핵산 및 미반응물들을 포함하는 혼합물로부터 표지화된 핵산만을 효율적으로 분리 정제하기 위한 간편하고도 효율적이며, 표지자의 친수성/소수성 여부에 관계없이 범용적으로 사용할 수 있는 방법을 제공한다. The present invention is a simple and efficient method for efficiently separating and purifying only the labeled nucleic acid from a mixture containing a chemical marker and a nucleic acid capable of reacting with the chemical marker and a nucleic acid labeled with a non-reactant, And provides a method that can be used universally.
또한, 본 발명은 상기 분리정제 방법을 이용하여 표지화된 핵산의 분리 정제하는데 사용할 수 있는 키트에 관한 것이다.The present invention also relates to a kit that can be used for the separation and purification of labeled nucleic acids using the above separation and purification method.
상기 목적을 달성하기 위하여, 본 발명은 a) 화학적 표지자 및 상기 화학적 표지자와 반응가능한 핵산을 수용액상에서 반응시켜 반응용액을 준비하는 단계; b) 상기 반응용액의 pH를 미리 설정된 범위내로 조절하는 단계; c) 상기 pH가 조절된 반응용액에 수용액층 및 유기용매층으로 분리되는 유기 용매를 첨가하고 교반하여 혼합 용액을 제조하는 단계; 및 d) 상기 유기 용매의 적어도 일부를 제거하는 단계;를 포함하는 화학적으로 표지된 핵산의 분리 정제 방법을 제공한다.In order to achieve the above object, the present invention provides a method for preparing a nucleic acid comprising the steps of: a) preparing a reaction solution by reacting a chemical marker and a nucleic acid capable of reacting with the chemical marker in an aqueous solution; b) adjusting the pH of the reaction solution to within a predetermined range; c) adding an organic solvent separated into the aqueous solution layer and the organic solvent layer to the pH-adjusted reaction solution, and stirring to prepare a mixed solution; And d) removing at least a portion of the organic solvent.
일 실시예로서, 상기 c) 단계에서 첨가되는 유기 용매는 물(H2O)을 포함할 수 있다.In one embodiment, the organic solvent added in the step c) may include water (H2O).
일 실시예로서, 상기 유기 용매는 물(H2O)이 포화된 상태의 유기용매를 사용할 수 있다.In one embodiment, the organic solvent may be an organic solvent in which water (H20) is saturated.
일 실시예로서, 상기 b) 단계에서, 미리 설정된 반응용액의 pH는 화학적 표지자의 pKa보다 낮은 범위일 수 있고, 이경우에, 상기 b) 단계는 화학적 표지자의 pKa보다 낮은 pH로 맞춰진 수용액과 상기 반응용액을 혼합함으로써, 혼합된 반응 용액의 pH를 미리 설정된 범위내로 조절할 수 있다.In one embodiment, in the step b), the pH of the predetermined reaction solution may be in a range lower than the pKa of the chemical marker, and in this case, the step b) may be carried out by mixing the aqueous solution adjusted to pH lower than the chemical marker pKa, By mixing the solution, the pH of the mixed reaction solution can be adjusted within a predetermined range.
일 실시예로서, 추가로 e) 상기 b) 내지 d) 단계를 1 회 이상 수행하는 단계를 포함할 수 있다.In one embodiment, e) further comprises performing the steps b) to d) one or more times.
일 실시예로서, 상기 화학적 표지자는 소수성 형광염료 또는 친수성 형광염료일 수 있다.In one embodiment, the chemical marker may be a hydrophobic fluorescent dye or a hydrophilic fluorescent dye.
일 실시예로서, 상기 핵산이 올리고 핵산일 수 있다.In one embodiment, the nucleic acid may be an oligonucleotide.
일 실시예로서, 상기 화학적 표지자가 Alexa 488, Cy 5, ATTO 633, Cy 3, Cy 3B, ATTO 550, ATTO 390, ATTO 647N, Rhodamine 6G, Nile red 중에서 선택되는 적어도 하나 이상일 수 있다.In one embodiment, the chemical marker may be at least one selected from Alexa 488, Cy 5, ATTO 633, Cy 3, Cy 3B, ATTO 550, ATTO 390, ATTO 647N, Rhodamine 6G and Nile red.
일 실시예로서, 상기 유기 용매가 log P 값이 0.6 내지 4.0 인 유기 용매일 수 있다.In one embodiment, the organic solvent may be an organic solvent having a log P value of 0.6 to 4.0.
일 실시예로서, 상기 유기 용매가 탄소수 3 내지 8 의 알코올, 탄소수 3 내지 8의 에테르, 클로로포름, 탄소수 2 내지 6의 알킬 아세테이트, 탄소수 6 내지 12의 방향족 탄화수소, 탄소수 5 내지 14의 선형 또는 분지형 알칸, 탄소수 5 내지 14의 시클로알칸, 탄소수 5 내지 12의 선형 또는 분지형 알킬기 및 탄소수 5 내지 12의 시클로알킬기를 갖는 탄화수소, 1,1,1-트리클로로에탄 중에서 선택되는 1종 또는 이들의 혼합액일 수 있다.In one embodiment, the organic solvent is selected from the group consisting of alcohols having 3 to 8 carbon atoms, ether having 3 to 8 carbon atoms, chloroform, alkyl acetates having 2 to 6 carbon atoms, aromatic hydrocarbons having 6 to 12 carbon atoms, linear or branched An alkane, a cycloalkane having 5 to 14 carbon atoms, a linear or branched alkyl group having 5 to 12 carbon atoms, a hydrocarbon having a cycloalkyl group having 5 to 12 carbon atoms, a 1,1,1-trichloroethane or a mixture thereof Lt; / RTI >
일 실시예로서, 상기 c) 단계와 d) 단계 사이에 상기 혼합 용액을 원심 분리하는 단계를 포함할 수 있다.In one embodiment, it may include centrifuging the mixed solution between steps c) and d).
또한, 본 발명의 일 구현예로서, 핵산과 반응 가능한 화학적 표지자를 포함하며, 수용액을 포함하는 핵산이 투입되는 경우에, 상기 핵산과 화학적 표지자가 반응할 수 있는 제1 용기; 소정의 pH값을 가지는 산성 수용액을 포함하는 제3 용기; 및 물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기;를 포함하며, 상기 제3 용기내 산성 수용액의 pH는, 상기 제1용기내의 화학적 표지자가 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트를 제공한다.According to an embodiment of the present invention, there is provided a method of detecting a nucleic acid, comprising the steps of: (a) providing a first container containing a chemical marker capable of reacting with a nucleic acid and capable of reacting with the nucleic acid; A third container containing an acidic aqueous solution having a predetermined pH value; And a fourth container containing an organic solvent containing at least a part of water (H2O), wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid, Wherein the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker.
또 다른 본 발명의 일 구현예로서, 본 발명은 핵산과 반응 가능한 화학적 표지자를 포함하는 제1 용기; 수용액을 포함하며, 상기 제1용기내 화학적 표지자와 핵산을 반응시키기 위한 제2 용기; 소정의 pH값을 가지는 산성 수용액을 포함하는 제 3 용기; 및 물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기;를 포함하며, 상기 제3 용기내 산성 수용액의 pH는, 상기 제1용기내의 화학적 표지자가 제2 용기 내에서 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트를 제공한다.In another embodiment of the present invention, the present invention provides a pharmaceutical composition comprising a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; Wherein the pH of the acidic aqueous solution in the third container is such that the chemical markers in the first container are in contact with the nucleic acid in the second container, Wherein the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the reaction is set to be lower than the pKa of the chemical markers.
또한 본 발명은 핵산과 반응 가능한 화학적 표지자를 포함하는 제1 용기; 수용액을 포함하며, 상기 제1용기내 화학적 표지자와 핵산을 반응시키기 위한 제2 용기; 소정의 pH값을 가지는 산성 수용액을 포함하는 제 3 용기; 및 물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기; 및 상기 화학적 표지자와 반응 가능한 핵산을 포함하는 제5 용기;를 포함하며, 상기 제3 용기내 산성 수용액의 pH는, 상기 제1용기내의 화학적 표지자가 제2 용기 내에서 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트를 제공한다.The present invention also relates to a pharmaceutical composition comprising a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; And an organic solvent containing at least a part of water (H2O); Wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid in the second container, Wherein the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker.
이 경우에 본 발명에 따른 상기 표지화된 핵산의 분리 정제용 키트내 유기용매는 물을 포화상태로 포함할 수 있다. In this case, the organic solvent in the kit for separating and purifying the labeled nucleic acid according to the present invention may contain water in a saturated state.
또한, 상기 표지화된 핵산의 분리 정제용 키트는 상기 화학적 표지자와 핵산이 반응 후, 상기 제3 용기의 산성 수용액을 혼합함에 있어, pH를 조정하기 위한 염기성 수용액을 포함하는 용기를 추가적으로 구비할 수 있고, 또한 유기용매와 수용액을 분리할 수 있는 분리장치를 추가적으로 포함할 수 있다. The kit for separation and purification of the labeled nucleic acid may further comprise a container containing a basic aqueous solution for adjusting the pH of the acidic aqueous solution of the third container after the chemical marker and the nucleic acid are reacted, , And a separation device capable of separating the organic solvent and the aqueous solution.
본 발명에 따르면, 화학적 표지자로 사용되는 형광물질(Dye)의 친수성 및 소수성 성질과 관련없이 핵산과 화학적 표지자의 반응에 따른 반응 혼합물 수용액의 pH를 조절함으로써 표지화에 이용된 표지자의 중성상태를 유도하여 유기용매층에 대한 용해도를 증가시킴으로써 미반응의 표지자를 용이하게 분리 제거할 수 있다.According to the present invention, the neutral state of the marker used for labeling is induced by controlling the pH of the reaction mixture aqueous solution according to the reaction between the nucleic acid and the chemical marker irrespective of the hydrophilic and hydrophobic properties of the fluorescent substance (Dye) used as a chemical marker By increasing the solubility in the organic solvent layer, unreacted markers can be easily separated and removed.
즉, 화학적 표지자로 사용되는 형광물질(Dye)이 양성자 이온을 방출하여 전리하는 경우에 이의 고유한 pKa값보다 낮은 범위로 pH를 제어함으로써, 표지자의 종류에 상관없이 다양한 종류의 미반응 표지자를 고효율로 용이하게, 표지화된 핵산을 분리 정제할 수 있는 신규한 방법 및 이를 이용한 키트를 제공할 수 있다.That is, when a fluorescent substance (Dye) used as a chemical marker is released by proton ions and then ionized, the pH is controlled to a range lower than the inherent pKa value, so that various kinds of unreacted markers can be efficiently A novel method capable of easily separating and purifying a labeled nucleic acid, and a kit using the same.
도 1은 통상적으로 사용되는 화학적 표지자들의 pH 범위(pH=1.8~9)에 따른 각각의 재료들의 흡광도의 변화를 도시한 그래프이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a graph showing changes in the absorbance of the respective materials according to the pH range (pH = 1.8 to 9) of commonly used chemical markers. FIG.
도 2는 본 발명에 따른, 수용액상의 pH 제어를 통하여 표지화된 올리고 핵산을 제조하기 위한 화학적 표지자와 핵산과의 반응으로부터 미반응 염료를 제거하는 방법을 예시적으로 나타낸 개념도이다.2 is a cross- FIG. 7 is a conceptual diagram illustrating a method for removing unreacted dyes from a reaction with a nucleic acid and a chemical marker for preparing labeled oligonucleic acid through pH control of an aqueous solution according to the present invention.
도 3은 본 발명에 따른 실시예 (실시예1 ,2, 3) 및 비교예 (비교예1 ,2, 3)에 따른 일정 PH 조건하에서 하부의 수용액층과 상부의 유기용매층으로 핵산(DNA)과 형광 염료가 분배된 정도를 나타내는 실제 사진이다. FIG. 3 is a graph showing the relationship between the amount of nucleic acid (DNA) and the amount of nucleic acid (nucleic acid) added to the lower aqueous solution layer and the upper organic solvent layer under constant PH conditions according to Examples (Examples 1, 2, ) And the degree of distribution of the fluorescent dye.
도 4의 A는 본 발명에서의 비교예 1에 따른, pH=8.5 조건하에서 유기용매를 처리하여 수용액과 유기용매에 분배되어 분리된 후 수용액 상에 잔존하는 형광염료(Cy 5)와 핵산(DNA)의 농도를 유기용매를 처리한 각 단계별로 도시한 그래프이다. FIG. 4A is a graph showing the results obtained by treating an organic solvent under pH = 8.5 conditions according to Comparative Example 1 of the present invention, separating it into an aqueous solution and an organic solvent, separating the fluorescent dye (Cy 5) ) Was treated with an organic solvent.
도 4의 B는 본 발명에 따른 실시예 1에 따른 pH=3 조건하에서 유기용매를 처리하여 수용액과 유기용매에 분배되어 분리된 후 수용액 상에 잔존하는 형광염료(Cy 5)와 핵산(DNA)의 농도를 유기용매를 처리한 각 단계별로 도시한 그래프이다. FIG. 4 (B) is a graph showing the relationship between the fluorescence dye (Cy 5) and the nucleic acid (DNA) remaining after being dispersed in an aqueous solution and an organic solvent after being treated with an organic solvent under pH = 3 according to Example 1 of the present invention, Is a graph showing the concentration of the organic solvent treated in each step.
도 5는 종래 기술에 따른 에탄올 재결정법(도 5의 상부 그래프)과 본 발명에 따른 실시예1에 따른 pH 제어를 이용한 용매 추출법(도 5의 하부 그래프)에 의해 분리 정제된 수용액상의 혼합물(Cy 5와 DNA)을 각각 액체크로마토그래피(HPLC)를 이용하여 분리한 결과이다.FIG. 5 is a graph showing the relationship between the concentration of the mixture (Cy (1)) in the aqueous solution separated and purified by the conventional ethanol recrystallization method (upper graph in FIG. 5) and the solvent extraction method 5 and DNA) were separated by liquid chromatography (HPLC), respectively.
도 6의 A는 종래 기술에 따른 에탄올 재결정법(도 6의 상부좌측 그래프)과 본 발명에 따른 실시예1에 따른 pH 제어를 이용한 용매 추출법(도 6의 상부우측 그래프)에 의해 분리 정제된 수용액상의 혼합물(Cy 5와 dsDNA)을 공초점 현미경(confocal microscopy)을 통하여 얻은 이미지이다.FIG. 6A is a graph showing the relationship between the amount of the aqueous solution separated and purified by the ethanol recrystallization method (upper left graph in FIG. 6) and the solvent extraction method using the pH control according to the first embodiment (upper right graph in FIG. 6) (Cy5 and dsDNA) were obtained through confocal microscopy.
도 6의 B는 종래 기술에 따른 에탄올 재결정법(도 6의 하부좌측 그래프)과 본 발명에 따른 실시예1에 따른 pH 제어를 이용한 용매 추출법(도 6의 하부우측 그래프)에 의해 분리 정제된 수용액상의 혼합물(Cy 5와 dsDNA)의 이미지의 픽셀당 광자수 및 최대 광자수를 나타낸 그래프이다.FIG. 6B is a graph showing the relationship between the amount of the aqueous solution separated and purified by the ethanol recrystallization method (lower left graph in FIG. 6) and the solvent extraction method using the pH control according to Example 1 (lower right graph in FIG. 6) (Cy 5 and dsDNA) on the photoreceptor of the present invention.
도 7의 A는 본 발명에 따른 실시예 4에 따른 pH 조절 분리정제법을 이용하여 미반응의 Cy3B 형광 염료를 분리한 후, pH 조건에 따라 수용액 상에 잔존하는 Cy3B의 흡광도를 나타낸 그래프이다.FIG. 7A is a graph showing the absorbance of Cy3B remaining in the aqueous solution according to the pH condition after the unreacted Cy3B fluorescent dye is separated using the pH controlled separation and purification method according to Example 4 of the present invention. FIG.
도 7의 B는 본 발명에 따른 실시예 4에 따른 pH=2 조건 하에서 미반응의 Cy3B 형광 염료를 분리한 후, 수용액 상에 잔존하는 Cy3B의 농도를 유기용매를 처리한 각 단계별로 도시한 그래프이다. 7B is a graph showing the concentration of Cy3B remaining in the aqueous solution after each of the unreacted Cy3B fluorescent dyes was separated under pH = 2 conditions according to Example 4 of the present invention, to be.
도 8은 도 8은 (A) ssDNA를 본 발명에 따른 조건(pH 3.0)에서 정제한 샘플 (B) ssDNA를 pH 8.5에서 보관한 샘플, (C) ssDNA를 pH 1.6, 38 ℃ 조건에서 2시간 동안 처리한 Depurinated sample, 및 (D) 구아닌(Guanine)과 아데닌(Adenine)을 포함하는 샘플의 HPLC(High Performance Liquid Chromatography) 결과를 나타낸 그래프이다. (B) ssDNA at pH 8.5, (C) ssDNA at pH 1.6 at 38 ° C for 2 hours (pH 3.0), (b) And (D) high performance liquid chromatography (HPLC) of samples containing guanine and adenine.
이하, 본 발명을 상세히 설명한다. 본문에 개시되어 있는 본 발명의 다양한 형태로 실시될 수 있으며 본문에 설명된 실시 예들에 한정되는 것으로 해석되지 아니할 것이다. Hereinafter, the present invention will be described in detail. But may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.
또한, 본 발명은 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있는바, 특정 실시 예들을 도면에 예시하고 본문에 상세하게 설명하고자 한다. 그러나 이는 본 발명을 특정한 개시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. In addition, the present invention is capable of various modifications and various forms, and specific embodiments are illustrated in the drawings and described in detail in the following description. It is to be understood, however, that the invention is not intended to be limited to the particular forms disclosed, but on the contrary, is intended to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
또한, 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 실시된 특징, 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다. Also, in the present application, the terms " comprises ", or " having ", etc. are intended to specify that there are performed features, numbers, steps, operations, elements, But do not preclude the presence or addition of one or more other features, integers, steps, operations, components, parts, or combinations thereof.
본 발명에 따른 화학적으로 표지된 핵산의 분리 정제 방법은 a) 화학적 표지자 및 상기 화학적 표지자와 반응가능한 핵산을 수용액상에서 반응시켜 반응용액을 준비하는 단계; b) 상기 반응용액의 pH를 미리 설정된 범위내로 조절하는 단계; c) 상기 pH가 조절된 반응용액에 수용액층 및 유기용매층으로 분리되는 유기 용매를 첨가하고 교반하여 혼합 용액을 제조하는 단계; 및 d) 상기 유기 용매의 적어도 일부를 제거하는 단계;를 포함한다. A method of separating and purifying a chemically-labeled nucleic acid according to the present invention comprises the steps of: a) preparing a reaction solution by reacting a chemical marker and a nucleic acid capable of reacting with the chemical marker in an aqueous solution; b) adjusting the pH of the reaction solution to within a predetermined range; c) adding an organic solvent separated into the aqueous solution layer and the organic solvent layer to the pH-adjusted reaction solution, and stirring to prepare a mixed solution; And d) removing at least a portion of the organic solvent.
이하, 본 발명에서 제시한 핵산의 분리 정제 방법의 각 단계별 공정에 대해서 구체적으로 살펴보고자 한다.Hereinafter, the respective steps of the method for separating and purifying nucleic acids proposed in the present invention will be described in detail.
본 발명의 상기 단계 a)에 있어서 화학적 표지자 및 상기 화학적 표지자와 반응가능한 핵산을 반응시키는 (핵산의) 표지화 반응은 수용액 내에서 통상적으로 공지된 일반적인 조건에서 수행될 수 있다. In step (a) of the present invention, the labeling reaction of the chemical marker and the nucleic acid capable of reacting with the chemical marker can be carried out under standard conditions generally known in aqueous solution.
이때, 반응 시간 및 반응온도는 특정 범위로 제한되지 않으나, 예를 들어, 0 ~ 50도의 범위에서 5분 내지 12시간의 범위에서 반응이 가능할 수 있고, 예컨대, 상기 표지화 반응은 상온(25 도)에서 2~3 시간 진행시킬 수 있다. In this case, the reaction time and the reaction temperature are not limited to a specific range. For example, the reaction may be performed in the range of 0 to 50 degrees for 5 minutes to 12 hours. For example, For 2 to 3 hours.
여기서, 화학적 표지자는 핵산의 몰 수보다 과량인 것이 반응 후 미반응의 핵산을 최소화한다는 점에서 바람직하며, 예를 들어, 1 배 이상, 바람직하게는 2 배 이상, 더욱 바람직하게는 5 배 이상, 더욱 바람직하게는 10 배 이상의 과량으로 사용될 수 있으며, 화학적 표지자의 비용 및 이후의 정제 과정을 감안하면 5 배 이상인 것이 바람직하다.Here, the chemical marker is excessively more than the number of moles of the nucleic acid in that it minimizes the unreacted nucleic acid after the reaction. For example, the chemical marker is at least 1 time, preferably at least 2 times, more preferably at least 5 times, More preferably 10 times or more, and it is preferably 5 times or more in view of the cost of the chemical marker and the subsequent purification process.
본 발명에서 사용되는 화학적 표지자는 당업계에서 핵산의 검출을 위한 표지자로 사용되는 것으로서, 이는 자외선, 적외선 또는 가시광선을 통해 감지할 수 있거나, 굴절율의 변화 등을 통해 감지할 수 있는 광학적 감지 물질, 또는 전기적으로 감지할 수 있는 물질을 포함할 수 있고, 통상적으로 형광 염료를 사용할 수 있다.The chemical markers used in the present invention are used as markers for the detection of nucleic acids in the art and include optical sensing materials that can be detected through ultraviolet, infrared or visible light, or can be detected through a change in refractive index, Or electrically detectable material, and typically a fluorescent dye can be used.
상기 형광염료는 통상적으로 친수성 형광 염료 및 소수성 형광 염료로 나뉘어질 수 있으며, 이들 친수성 형광 염료 또는 소수성 형광 염료들 모두 핵산과 용이하게 반응 할 수 있도록 핵산의 친핵체와 반응하는 경우 떨어져 나가게 되는 치환기인 이탈기(leaving group)를 포함할 수 있다.The fluorescent dyes may be generally divided into hydrophilic fluorescent dyes and hydrophobic fluorescent dyes. All of these hydrophilic fluorescent dyes or hydrophobic fluorescent dyes are substituted with a substituent which is removed when reacting with the nucleophile of the nucleic acid so as to easily react with the nucleic acid. And a leaving group.
상기 화학적 표지자로서 사용될 수 있는 형광염료의 일예로서, 아크리딘 호모다이머(Acridine homodimer) 및 이의 유도체, 아크리딘 오렌지(Acridine Orange) 및 이의 유도체, 7-아미노액티노마이신 D(7-aminoactinomycin D, 7-AAD) 및 이의 유도체, 액티노마이신 D(Actinomycin D) 및 이의 유도체, 에이씨엠에이(ACMA, 9-amino-6-chloro-2-methoxyacridine) 및 이의 유도체, 디에이피아이(DAPI) 및 이의 유도체, 디하이드로에티듐(Dihydroethidium) 및 이의 유도체, 에티듐 브로마이드(Ethidium bromide) 및 이의 유도체, 에티듐 호모다이머-1(EthD-1) 및 이의 유도체, 에티듐 호모다이머-2(EthD-2) 및 이의 유도체, 에티듐 모노아자이드(Ethidium monoazide) 및 이의 유도체, 헥시디움 아이오다이드(Hexidium iodide) 및 이의 유도체, 비스벤지마이드(bisbenzimide, Hoechst 33258) 및 이의 유도체, 호에크스트 33342(Hoechst 33342) 및 이의 유도체, 호에크스트 34580(Hoechst 34580) 및 이의 유도체, 하이드로옥시스티바미딘(hydroxystilbamidine) 및 이의 유도체, 엘디에스 751(LDS 751) 및 이의 유도체, 프로피디움 아이오다이드(Propidium Iodide, PI) 및 이의 유도체, 사이다이스(Cy-dyes) 유도체로 이루어진 군에서 임의로 선택될 수 있으며, 구체적으로 상기 화학적 표지자가 Alexa 488, Cy 5, ATTO 633, Cy 3, Cy 3B, ATTO 550, ATTO 390, ATTO 647N, Rhodamine 6G, Nile red 중에서 선택되는 적어도 하나 이상인 것이 바람직하다.Examples of fluorescent dyes that can be used as the chemical markers include Acridine homodimer and derivatives thereof, Acridine Orange and derivatives thereof, 7-aminoactinomycin D , 7-AAD) and derivatives thereof, Actinomycin D and derivatives thereof, ACMA (9-amino-6-chloro-2-methoxyacridine and derivatives thereof, DAPI) Ethidium bromide and derivatives thereof, ethidium homodimer-1 (EthD-1) and derivatives thereof, ethidium homodimer-2 (EthD-2) and derivatives thereof, dihydroethidium and derivatives thereof, ethidium bromide and derivatives thereof, And derivatives thereof, Ethidium monoazide and derivatives thereof, Hexidium iodide and derivatives thereof, bisbenzimide (Hoechst 33258) and derivatives thereof, Hoechst 33342 ) And its oil Hydroxystilbamidine and derivatives thereof, LDS 751 and derivatives thereof, Propidium Iodide (PI), and derivatives thereof, as well as derivatives thereof, Cy3, Cy3B, ATTO550, ATTO39O, ATTO647N, and ATTO647N. The chemical markers may be selected from the group consisting of Ala, Rhodamine 6G, and Nile red.
한편, 상기 화학적 표지자로서 형광 발색단 염료를 이용한 표지가 바람직하나, 다른 형태의 검출가능한 표지도 당업자에게 유용한 것은 자명하다. 예를 들면, 퀀텀 도트(Empodocles 등, Nature 399:126-130, 1999)를 포함한 미크로입자, 금 나노입자 (Reichert 등, Anal. Chem. 72:6025-6029, 2000), 및 마이크로비드 (Lacoste 등, Proc. Natl. Acad. Sci USA 97(17):9461-9466, 2000)가 음전하성 리간드로 또는 양전하성 리간드로 코팅되서 일정 PH범위에서 비이온성으로 표면 전하 조절이 가능한 경우라면 모두 사용될 수 있다.On the other hand, labeling using a fluorescent chromophore dye is preferred as the chemical marker, but it is apparent that other forms of detectable labeling are also available to those skilled in the art. For example, microparticles, gold nanoparticles (Reichert et al., Anal. Chem. 72: 6025-6029, 2000) and microbeads (Lacoste et al. , Proc. Natl. Acad. Sci. USA 97 (17): 9461-9466, 2000) can be used either as negative chargeable ligands or as positively charged ligands, so that surface charge control at non- .
한편, 본 발명에서 화학적 표지자와 반응가능한 핵산은 당, 인산, 염기를 포함하는 수용성의 고분자로서, DNA 또는 RNA 또는 이들의 혼합물을 의미하며, 본 발명에서 핵산은 올리고 핵산 및 올리고 핵산보다 많은 뉴클레오티드 개수를 갖는 폴리뉴클레오티드를 모두 포함한다. 여기서, 올리고 핵산은 뉴클레오티드의 개수가 100 이하 또는 50 이하인 것을 의미한다.In the present invention, a nucleic acid capable of reacting with a chemical marker in the present invention is a water-soluble polymer including a sugar, a phosphoric acid and a base, and it means DNA or RNA or a mixture thereof. In the present invention, the nucleic acid means a nucleic acid having more nucleotides than the oligonucleic acid and oligonucleotide Lt; RTI ID = 0.0 > polynucleotides < / RTI > Herein, the oligonucleotide means that the number of nucleotides is 100 or less or 50 or less.
본 발명의 상기 a) 단계에서 핵산은 화학적 표지자와 결합할 수 있도록 선처리되며, 이는 화학적 표지자와 반응가능한 작용기를 핵산에 도입시키거나, 이미 작용기가 도입된 핵산을 상업적으로 구입하는 방법을 통해 입수할 수 있다.In step a) of the present invention, the nucleic acid is pre-treated so as to bind to a chemical marker, which is obtained by introducing a functional group capable of reacting with a chemical marker into the nucleic acid, or by commercially purchasing a nucleic acid already having a functional group introduced thereto .
일반적으로, 핵산과 표지자의 결합 방법으로는 1차 아민기 또는 티올기와 같은 친핵성 작용기를 갖는 핵산을, 친전자성 작용기로 관능화된 형광 염료 또는 프로브 등과 같은 표지자와 반응시킴으로써 표지화된 핵산을 제조하는 방법을 사용할 수 있으며, 핵산의 작용기와 표지자는 기타 연결기를 통해서도 연결될 수 있다.Generally, as a method for binding a nucleic acid with a marker, a nucleic acid having a nucleophilic functional group such as a primary amine group or a thiol group is reacted with a marker such as a fluorescent dye or a probe functionalized with an electrophilic functional group to produce a labeled nucleic acid , And the functional groups and markers of the nucleic acid can be linked through other linkages.
여기서, 상기 화학적 표지자와의 반응을 통하여 화학적 표지자와 핵산이 결합될 수 있는 것이라면, 핵산에 존재하거나 새로이 부착되는 작용기의 종류는 한정되지 않으며, 다만 화학적 표지자와의 반응성을 고려하여 상기 핵산내 포함될 작용기(관능기)가 선택될 수 있다. 예를 들어, 친핵성 작용기로는 1차 아민기 또는 티올기 등이 있으며, 예컨대, 핵산의 작용기가 1차 아민기인 경우, 화학적 표지자는 에스테르, 이소티오시아네이트, 이소시아네이트, 아실 아자이드, NHS 에스테르, 염화설포닐, 알데히드 등과 같은 작용기를 포함할 수 있고, 핵산의 작용기가 티올기인 경우에는, 표지자는 할로아세틸, 알킬 할라이드 유도체, 말레이미드, 아지리딘 등과 같은 작용기를 포함할 수 있고, 이 중, 1차 아민기가 바람직하게 사용될 수 있다.Here, if the chemical marker and the nucleic acid can be combined through the reaction with the chemical marker, the kind of the functional group present or newly attached to the nucleic acid is not limited. However, considering the reactivity with the chemical marker, (Functional group) can be selected. For example, the nucleophilic functional group includes a primary amine group or a thiol group. For example, when the functional group of the nucleic acid is a primary amine group, the chemical marker is an ester, isothiocyanate, isocyanate, acyl azide, NHS ester , Sulfonyl chloride, aldehyde, and the like. When the functional group of the nucleic acid is a thiol group, the label may include functional groups such as haloacetyl, alkyl halide derivatives, maleimide, aziridine, etc., A primary amine group may be preferably used.
상기와 같은 작용기를 핵산에 부착시킴으로써 화학적 표지자와 결합 가능한 핵산을 제조하는 방법은 상기 예시적으로 기재된 방법 이외에도 본 기술분야의 통상적인 방법을 통해 수행할 수 있다.The method for producing a nucleic acid capable of binding to a chemical marker by attaching such a functional group to a nucleic acid can be carried out by a conventional method in the art besides the above exemplified method.
한편, 본 발명에서의 상기 단계 b)는 앞서 화학적 표지자와 핵산과의 반응에 의해 얻어지는 반응용액의 pH를 미리 설정된 범위내로 조절하는 단계로서, 이를 통해 화학적 표지자의 이온화 상태를 변화시켜 후속공정인 단계 c)에서 유기용매를 혼합함으로써, 유기층과 수용액층이 서로 분리되는 경우에 상기 수용액상과 유기용매상에서 용해도 차이에 따라 미반응 화학적 표지자를 효과적으로 제거할 수 있도록 하며, 이는 본 발명의 기술적 특징에 해당한다. The step b) of the present invention is a step of adjusting the pH of the reaction solution obtained by the reaction of the chemical marker with the nucleic acid to a predetermined range, thereby changing the ionization state of the chemical marker, When the organic layer and the aqueous solution layer are separated from each other by mixing the organic solvent in c), the unreacted chemical markers can be effectively removed according to the difference in solubility between the aqueous solution and the organic solvent. do.
본 발명에서 통상적으로 사용되는 반응용액의 pH 범위는 pH1 ~ pH10의 범위일 수 있고, 바람직하게는 pH1 ~ pH7의 범위일 수 있으며, 더욱 바람직하게는 pH2 ~ pH5의 범위일 수 있으나 이에 제한되지 않는다.The pH range of the reaction solution usually used in the present invention may be in the range of pH 1 to pH 10, preferably in the range of pH 1 to pH 7, more preferably in the range of pH 2 to pH 5 .
한편, 상기 b) 단계에서, 미리 설정된 반응용액의 pH는 화학적 표지자의 pKa보다 낮은 범위를 유지하는 것이 바람직하다. 통상적으로, 상기 화학적 표지자의 경우에 수용액 상에서 약산성으로서 화학적 표지자의 음이온 부분과 수소 이온(proton, H+)으로 해리되는 물질을 사용할 수 있고, 이때 상기 표지자는 수용액상에서 중성상태 및 음이온 상태의 농도의 비가 하기 Henderson-Hasselbalch 식을 따르며, 하기 식 1에서 나타난 바와 같이 pH=pKa일 때, 음이온형과 비이온형의 농도가 같아진다.On the other hand, in the step b), it is preferable that the pH of the predetermined reaction solution is maintained in a range lower than the pKa of the chemical marker. Typically, in the case of the above-mentioned chemical markers, a substance which is weakly acidic in aqueous solution and which is dissociated into an anion portion of a chemical marker and a proton (H + ) can be used, wherein the marker has a neutral and anionic concentration The ratio follows the Henderson-Hasselbalch equation, and when pH = pKa as shown in Equation 1 below, the concentrations of anionic and non-ionic types become equal.
[식 1] pH = pKa + log10([A-]/[HA]) [Equation 1] pH = pKa + log10 ( [A -] / [HA])
상기 식 1에 따라서 미반응의 화학적 표지자를 포함하는 반응용액의 혼합물 수용액내의 pH가 화학적 표지자의 pKa 값보다 큰 경우에는 음전하를 띈 이온상태의 화학적 표지자의 농도가 중성상태의 화학적 표지자의 농도보다 높아져서 결과적으로 이온상태의 표지자는 수용액상에서 보다 높은 용해도를 띄게 되며, 따라서, 화학적 표지자의 pKa값보다 높은 pH 조건의 수용액상에서 미반응의 표지자를 유기용매층으로 추출하여 분리하지 못한다. When the pH of the mixture solution of the reaction solution containing unreacted chemical markers is greater than the pKa value of the chemical markers according to the above formula 1, the concentration of the ionic chemical markers having a negative charge becomes higher than that of the neutral markers As a result, the ionic indicator becomes more soluble in the aqueous solution, and therefore, the unreacted marker can not be extracted and separated into the organic solvent layer in an aqueous solution of pH higher than the pKa value of the chemical marker.
이와 반대로, 상기 식 1에 따라서 미반응의 화학적 표지자를 포함하는 반응용액의 혼합물 수용액내의 pH가 화학적 표지자의 pKa 값보다 작은 경우 중성상태의 화학적 표지자의 농도가 지배적이며, 이러한 중성상태의 화학적 표지자는 유기용매상에 보다 높은 용해도를 가질 수 있게 된다. Conversely, when the pH of the mixture solution of the reaction solution containing unreacted chemical markers is less than the pKa value of the chemical markers according to the above formula 1, the concentration of neutral chemical markers is dominant, and the chemical markers of such neutral states It becomes possible to have a higher solubility in the organic solvent phase.
이러한 원리를 이용하여 핵산과 미반응된 화학적 표지자를 포함하는 혼합물 수용액에 일정 양의 유기용매를 혼합하고 이후 층분리를 유도함으로써, 유기용매층으로 미반응의 중성상태의 화학적 표지자를 추출하여 분리하게 되면 보다 효율적이면서도 용이하게 미반응된 화학적 표지자를 제거할 수 있다. By using this principle, an unreacted neutral chemical marker is extracted and separated into an organic solvent layer by mixing a certain amount of an organic solvent with an aqueous solution of the mixture containing a nucleic acid and an unreacted chemical marker and then inducing the layer separation It is possible to remove unreacted chemical markers more efficiently and easily.
따라서, 본 발명에서 화학적 표지자의 pKa 값보다 낮은 pH에서 존재하는 중성상태의 화학적 표지자를 유기용매로 추출하여 분리하는 원리를 사용함으로써 화학적 표지자로서 소수성의 화학적 표지자와 친수성의 화학적 표지자 모두 사용될 수 있는 장점이 있다.Therefore, in the present invention, by using a principle of extracting and separating a neutral chemical marker existing at a pH lower than the pKa value of a chemical marker by an organic solvent, it is possible to use both a hydrophobic chemical marker and a hydrophilic chemical marker as chemical markers .
한편, 본 발명에서 상기 반응용액의 pH 조건을 맞추기 위해서 일정한 농도의 산성 용액이 사용될 수 있으며, 바람직하게는 강산으로 분류되는 HNO3, HClO4, H2SO4, HCl, HBr, HI 등을 물에 녹여서 이를 이용할 수 있다. In order to adjust the pH of the reaction solution, an acidic solution having a predetermined concentration may be used. Preferably, HNO 3, HClO 4, H 2 SO 4, HCl, HBr, HI and the like, which are classified as strong acids, have.
이때, 상기 산성 용액 제조시 염기 반응에 의한 발열반응에 의한 사고를 막기 위해서 피펫 등의 기구를 통해서 수용액이 많은 조건하에서 상기 수용액 산을 소량씩 첨가하는 것이 바람직하다. At this time, in order to prevent an accident caused by an exothermic reaction due to a base reaction in the production of the acidic solution, it is preferable to add the aqueous solution acid in small quantities under a condition of a large amount of aqueous solution through a mechanism such as a pipette.
즉, 본 발명에서의 상기 b) 단계는 화학적 표지자의 pKa보다 낮은 pH로 맞춰진 수용액과 상기 반응용액을 혼합함으로써, 혼합된 반응 용액의 PH를 미리 설정된 범위내로 조절할 수 있으며, 이때, 상기 화학적 표지자의 pKa보다 낮은 pH로 맞춰진 수용액을 제조하기 위해서 산성 용액을 이용할 수 있다. That is, in the step b) of the present invention, the pH of the mixed reaction solution can be adjusted to a predetermined range by mixing the reaction solution with an aqueous solution adjusted to pH lower than the pKa of the chemical marker, An acidic solution can be used to prepare an aqueous solution adjusted to a pH lower than the pKa.
상기 반응용액을 화학적 표지자의 pKa 보다 낮은 pH로 맞춰진 수용액에 첨가하여 혼합시, 혼합 시간 및 혼합 효율을 증가시키기 위한 교반 방법 역시 한정되지 않으며, 단순 교반하거나, 흔들거나, 볼텍스 믹서 등의 기구를 사용하는 방법을 포함한다.The stirring method for adding the reaction solution to the aqueous solution adjusted to a pH lower than the pKa of the chemical marker and for increasing the mixing time and the mixing efficiency when mixing is not limited and it is also possible to use a stirring device such as simple stirring or shaking or using a vortex mixer .
한편, 본 발명에서 상기 산성용액 또는 산성용액과 반응용액의 혼합액의 pH 조건을 맞추기 위해서 상용화된 pH 측정기를 이용하여 측정하거나, 측정범위 1~14의 pH 시험지를 사용하여 본 발명의 pH 조건을 맞출 수 있다.Meanwhile, in the present invention, in order to adjust the pH conditions of the acid solution or the mixed solution of the acid solution and the reaction solution, the pH condition of the present invention may be adjusted by using a commercially available pH meter or using a pH test paper having a measurement range of 1 to 14 .
상기 화학적 표지자의 pKa 값은 전위차법 및 자외선/가시광선 분광법을 이용하여 측정할 수 있다. 도 1은 통상적으로 사용되는 화학적 표지자들의 pH 범위(pH=1.8~9)에 따른 각각의 재료들의 흡광도의 변화를 도시한 그래프로서, 본 발명에서는 자외선/가시광선 분광법을 통하여 pH=1.8~9.0 조건에서 흡광도를 나타낸 도 1로부터 형광염료의 흡광도가 1/2이 되는 지점이 음이온 상태의 표지자와 중성상태의 표지자의 농도가 같아짐에 따라, Henderson-Hasselbalch 식에서 pH=pKa 조건이 성립하고, 이러한 원리를 통해서 각각의 형광염료의 pKa 값을 실험적으로 얻을 수 있다. The pKa value of the chemical marker can be measured using a potential difference method and ultraviolet / visible light spectroscopy. FIG. 1 is a graph showing the change in absorbance of each of the materials according to the pH range (pH = 1.8 to 9) of commonly used chemical markers. In the present invention, pH = 1.8 to 9.0 under ultraviolet / visible ray spectroscopy 1, where the absorbance of the fluorescent dye is 1/2, the pH = pKa condition is established in the Henderson-Hasselbalch equation as the concentrations of the anion-state marker and the neutral-state marker become the same, The pKa value of each fluorescent dye can be experimentally obtained.
이는 산해리상수(pKa)는 산의 해리 반응이 발열 반응일 때와 흡열 반응일 때에 온도 의존도가 다르기 때문이다. 구체적으로 해리 반응이 흡열 반응을 경우 온도가 증가함에 따라 pKa 값이 감소하고, 해리반응이 발열 반응일 경우 온도가 증가함에 따라 pKa 값이 증가한다.This is because the acid dissociation constant (pKa) is dependent on the temperature dependence when the dissociation reaction of the acid is an exothermic reaction and the endothermic reaction. Specifically, when the dissociation reaction is an endothermic reaction, the pKa value decreases as the temperature increases, and when the dissociation reaction occurs as an exothermic reaction, the pKa value increases as the temperature increases.
*한편, 본 발명에서의 상기 단계 c)는 pH가 조절된 반응용액에 수용액층 및 유기용매층으로 분리되는 유기 용매를 첨가하고 교반하여 혼합 용액을 제조하는 단계로서, 상기 단계 c)에서 첨가되는 유기 용매의 양은 제한되지 않으나, 보다 빨리 미반응 표지자를 제거하고, 정제 횟수를 줄여 정제 시간을 단축시키기 위해서는 그 부피가 b) 단계의 혼합 수용액의 부피보다 과량인 것이 바람직하다. 예를 들어, 2 배 이상, 3 배 이상, 5 배 이상 또는 10 배 이상의 부피로 유기 용매를 첨가할 수 있다.Meanwhile, in the step c) of the present invention, an organic solvent separated into an aqueous solution layer and an organic solvent layer is added to a reaction solution whose pH is controlled, and stirred to prepare a mixed solution. Although the amount of the organic solvent is not limited, it is preferable that the volume of the organic solvent is excessively larger than the volume of the mixed aqueous solution of the step b) in order to remove the unreacted markers earlier and shorten the purification time by reducing the number of purification. For example, the organic solvent may be added at a volume of at least 2 times, at least 3 times, at least 5 times, or at least 10 times.
또한, 상기 단계 c)에서 사용되어 첨가되는 유기 용매는 유기용매내에 물(H2O)을 포함할 수 있고, 바람직하게는 상기 유기 용매는 물(H2O)이 포화된 상태의 유기용매를 사용하는 것이 더욱 바람직하다. In addition, the organic solvent used in step c) may include water (H2O) in the organic solvent, and preferably the organic solvent is an organic solvent in which water (H2O) is saturated desirable.
여기서, “물로 포화된 유기 용매”란 유기 용매가 물을 용해할 수있는 만큼 최대한 용해시켜 더 이상 물을 용해시키지 않고 용해 속도가 평형에 도달한 상태의 유기 용매를 말한다. 여기서, 유기 용매를 포화시키는 데 사용되는 물은 부수적인 영향을 최소화하기 위해 증류수가 바람직하게 사용될 수 있다.Here, the "organic solvent saturated with water" refers to an organic solvent in which the organic solvent dissolves as much as possible to dissolve the water so that the dissolution rate has reached equilibrium without further dissolving the water. Here, distilled water can be preferably used to minimize the incidental effect of the water used to saturate the organic solvent.
한편, 유기 용매를 물로 포화되지 않은 상태에서 사용할 경우에는 유기 용매를 첨가하고 교반하는 과정에서, 물 층의 일부 수분이 유기 용매 층에 용해될 수 있고, 이로 인해 물 층의 물의 양이 줄어드는 농축 현상이 발생할 수 있다. On the other hand, when the organic solvent is used in a state of being not saturated with water, in the process of adding and stirring an organic solvent, a part of water in the water layer can be dissolved in the organic solvent layer, Can occur.
또한, 단계 c) 에서 유기 용매를 첨가하는 경우에는 b) 단계의 혼합 수용액 부피보다 과량으로 유기 용매를 첨가하므로, 유기용매내에 물을 포함하지 않는 경우에는 층 분리될 물 층의 대부분의 물이 유기 용매 층에 용해되어 버림으로써, 화학적으로 표지화된 핵산을 포함하는 물 층과 미반응 표지자를 포함하는 유기 용매층이 층분리가 되지 않거나 또는 수용액층의 구별 내지는 분리가 어려울 수 있는 단점이 있게 된다.When the organic solvent is added in step c), the organic solvent is added in excess of the volume of the mixed aqueous solution in step b). Therefore, when water is not contained in the organic solvent, It is disadvantageous that the water layer containing the chemically labeled nucleic acid and the organic solvent layer containing the unreacted label may not be separated from each other or the aqueous solution layer may be difficult to be separated or separated.
따라서, 물을 포함하는 유기용매를 사용하거나 또는 물로 포화된 유기 용매를 사용할 경우에는, 유기 용매가 첨가되어 교반될 때, 층 분리에 따라 수용층에 존재하여야 하는 물이 유기 용매층에 더 이상 용해되어 이동하지 않음으로서, 수용액 층에 존재하는 표지화된 핵산의 농도에 영향을 미치지 않는 장점이 있다.Therefore, when an organic solvent containing water or an organic solvent saturated with water is used, when an organic solvent is added and stirred, water which should be present in the receptive layer due to layer separation is further dissolved in the organic solvent layer By not migrating, there is an advantage that it does not affect the concentration of the labeled nucleic acid present in the aqueous solution layer.
한편, 상기 c) 단계에서 교반하는 시간은 제한되지 않으며, 수 초 내지 수시간의 범위를 가질 수 있고, 대부분은 수초 내지 수분으로도 충분하며, 이의 교반하는 방법 역시 한정되지 않으며, 단순 교반하거나, 흔들거나, 볼텍스 믹서 등의 기구를 사용하는 방법을 포함할 수 있다.Meanwhile, the stirring time in the step c) is not limited, and may range from several seconds to several hours. Most of the time is sufficient for several seconds to several minutes, and the stirring method thereof is also not limited, Shaking, or using a device such as a vortex mixer.
한편, 본 발명은 미리 설정된 pH조건에서 화학적 표지자의 물과 유기용매에 대한 용해도 차이를 이용하는 것으로 일정 범위의 pH 조건에서 화학적 표지자의 분배계수가 2 이상을 가지는 유기 용매가 바람직하게 사용될 수 있다. In the meantime, the present invention utilizes the difference in solubility between water and an organic solvent of a chemical marker at a preset pH, and it is an object of the present invention to provide an organic solvent having a distribution coefficient of chemical markers of 2 or more at a pH range Can be preferably used.
[식 2] 분배 계수 = [Corganic]/[Cwater][Equation 2] Distribution coefficient = [Corganic] / [Cwater]
(식 중, [Corganic] 은 유기 용매에서의 화학적 표지자의 몰농도, [Cwater] 는 물에서의 화학적 표지자의 몰농도를 의미함).(Wherein [Corganic] is the molar concentration of the chemical marker in the organic solvent and [Cwater] is the molar concentration of the chemical marker in the water).
여기서, 상기 분배 계수(partition coefficient)는 두 개의 서로 섞이지 않은 액체 A, B 에, 어떤 물질이 일정한 온도와 압력하에서 용해하여 평형으로 달하였을 때, 각 용액 중의 농도 CA, CB 의 비, 즉, K=CA/CB 를 의미하며, 상기 분배 계수는, UV/VIS 스펙트로미터(sptectrometer)를 통해, 유기 용매에서의 화학적 표지자의 농도 및 물에서의 화학적 표지자의 농도를 측정하여 구할 수 있다.Herein, the partition coefficient is a ratio of the concentration of CA to the concentration of CB in each solution when the substance dissolves in equilibrium at a certain temperature and pressure in two unmixed liquids A and B, that is, K = CA / CB, and the partition coefficient can be obtained by measuring the concentration of a chemical marker in an organic solvent and the concentration of a chemical marker in water via a UV / Vis spectrometer (sptectrometer).
상기 분배 계수는 물과 유기 용매에 대해 어느 용매에 대한 용해도가 높은지를 보이는 지표로서, 본 발명에서는 화학적으로 표지화된 핵산의 분리 정제에 사용되는 화학적 표지자와 유기 용매의 상관관계를 나타내며, 상기 분배계수의 관계를 만족하는 중성상태의 화학적 표지자와 유기 용매라면, 그 종류가 제한되지 않는다.The partition coefficient is an index showing the solubility of a solvent in water and an organic solvent. In the present invention, a correlation between a chemical marker used for separation and purification of a chemically labeled nucleic acid and an organic solvent, The kind of the chemical marker and the organic solvent are not limited.
본 발명에서 중성상태의 화학적 표지자는 물과 유기 용매에 대한 분배 계수가 2 이상, 바람직하게는 10 이상, 더욱 바람직하게는 25 이상, 더욱 바람직하게는 50 이상, 더욱 바람직하게는 100 이상, 더욱 바람직하게는 200 이상, 더욱 바람직하게는 300 이상이 되도록 유기용매 및 화학적 표지자와의 조합이 사용될 수 있으며, 분배 계수가 클수록 표지화된 핵산과 미반응 표지자의 분리가 용이할 수 있다.In the present invention, the chemical markers in the neutral state have a partition coefficient of 2 or more, preferably 10 or more, more preferably 25 or more, still more preferably 50 or more, still more preferably 100 or more, , More preferably 200 or more, and more preferably 300 or more. The larger the partition coefficient, the easier separation of the labeled nucleic acid from the unreacted marker.
즉, 상기 분배계수는 일정 pH 조건에 따라서 분배계수의 값이 달라지며, 도 3은 pH 조건에 따라서 수용액층과 유기용매로서 헥산을 사용한 경우에 핵산층과의 형광 염료가 분배된 정도를 나타내며, 낮은 pH조건에서 형광 염료의 유기용매층에 대한 분배도가 높아짐을 나타내고 있다.That is, the value of the partition coefficient varies depending on a constant pH condition. FIG. 3 shows the distribution of fluorescent dyes between the nucleic acid layer and the aqueous solution layer and hexane as the organic solvent, The distribution of the fluorescent dye to the organic solvent layer is increased under the low pH condition.
한편, 본 발명에서 사용되는 유기 용매는 물과 층이 분리될 수 있는 유기 용매로서, 수용액층과 유기용매층이 분리될 수 있는 유기 용매라면 그 종류가 특별히 한정되지 않는다.The organic solvent used in the present invention is not particularly limited as long as it is an organic solvent from which water and a layer can be separated and in which an aqueous solution layer and an organic solvent layer can be separated.
여기서, 상기 유기용매의 Log P 값이 0.6 미만인 경우에는 물과 유기 용매의 층이 잘 분리되지 않으므로 본 발명에서는 log P 값이 0.6 이상인 유기 용매가 사용될 수 있다.When the Log P value of the organic solvent is less than 0.6, the water and the organic solvent layer are not separated well. Therefore, an organic solvent having a log P value of 0.6 or more may be used in the present invention.
여기서, log P 값은, 옥탄올과 물의 동일 몰 혼합액에 대한 유기 용매의 분배 계수(Partition coefficient) 를 의미하는 P 의 log 값을 의미한다.Here, the log P value means the log value of P, which means the partition coefficient of the organic solvent for the same molar mixture of octanol and water.
한편, 유기 용매의 log P 값의 상한은 한정되지 않으나, log P 값이 너무 높은 경우에는 중성상태의 화학적 표지자가 오히려 물에 더 잘 용해될 수 있으므로, 중성상태의 화학적 표지자와 유기 용매가 상기 식 2 로 표시되는 분배계수가 2 이상인 것을 만족하는지를 확인함으로써 적절한 유기 용매를 선택할 수 있다.On the other hand, the upper limit of the log P value of the organic solvent is not limited, but if the log P value is too high, the chemical markers of the neutral state may be dissolved in the water rather well, so that the chemical markers of neutral state and the organic solvent 2 is satisfied, it is possible to select an appropriate organic solvent.
일반적인 중성상태의 화학적 표지자와의 관계에서 바람직하게 사용될 수 있는 유기 용매는 log P 값이 0.6 내지 4.0 인 범위의 유기 용매이며, 보다 바람직하게는, log P 값이 0.6 내지 3.5 인 범위의 유기 용매, 보다 바람직하게는, log P 값이 0.6 내지 3.0 인 범위의 유기 용매이다.Organic solvents which can be preferably used in relation to chemical markers in general neutral state are organic solvents having a log P value in the range of 0.6 to 4.0, more preferably organic solvents having a log P value in the range of 0.6 to 3.5, More preferably, it is an organic solvent having a log P value in the range of 0.6 to 3.0.
이러한 log P 값이 0.6 내지 4.0 인 유기 용매의 예로는, 탄소수 3 내지 8 의 알코올, 탄소수 3 내지 8의 에테르, 클로로포름, 탄소수 2 내지 6의 알킬 아세테이트, 탄소수 6 내지 12의 방향족 탄화수소, 탄소수 5 내지 14의 선형 또는 분지형 알칸, 탄소수 5 내지 14의 시클로알칸, 탄소수 5 내지 12의 선형 또는 분지형 알킬기 및 탄소수 5 내지 12의 시클로알킬기를 갖는 탄화수소, 1,1,1-트리클로로에탄 중에서 선택되는 1종 또는 이들의 혼합액이 사용될 수 있으며, 바람직하게는 1-부탄올, 이소아밀알코올, 펜탄올 등의 탄소수 4 내지 8 의 알코올, 에틸 아세테이트, 디에틸에테르, 디이소프로필 에테르, 부틸 아세테이트, 클로로포름, 벤젠, 1,1,1-트리클로로에탄, 톨루엔, 헥센 등을 사용할 수 있다.Examples of such organic solvents having a log P value of 0.6 to 4.0 include alcohols having 3 to 8 carbon atoms, ethers having 3 to 8 carbon atoms, chloroform, alkyl acetates having 2 to 6 carbon atoms, aromatic hydrocarbons having 6 to 12 carbon atoms, A linear or branched alkane having 1 to 14 carbon atoms, a cycloalkane having 5 to 14 carbon atoms, a linear or branched alkyl group having 5 to 12 carbon atoms and a cycloalkyl group having 5 to 12 carbon atoms, 1,1,1-trichloroethane 1-butanol, isoamyl alcohol and pentanol; alcohols having 4 to 8 carbon atoms, such as ethyl acetate, diethyl ether, diisopropyl ether, butyl acetate, chloroform, Benzene, 1,1,1-trichloroethane, toluene, hexene and the like can be used.
본 발명에서의 마지막 단계에 해당하는 단계 d)는 상기 유기 용매의 적어도 일부를 제거하는 단계로서, 미반응 화학적 표지자를 주로 포함하고 있는 유기용매를 적어도 일부 제거하며, 바람직하게는 층분리된 유기층내 대부분의 유기 용매를 제거할 수 있다. 상기 유기 용매 제거를 위한 방법으로는 통상적으로 사용되는 방법을 사용할 수 있고, 연속공정에서는 데칸터를 사용하고 배치공정에서는 분별 깔대기등을 사용할 수 있고, 양이 적은 경우에는 피펫 등을 이용하여 유기용매를 제거할 수 있다. Step d) of the last step in the present invention is a step of removing at least a part of the organic solvent, at least partially removing an organic solvent mainly comprising unreacted chemical markers, preferably in a layered organic layer Most organic solvents can be removed. As a method for removing the organic solvent, a commonly used method can be used. In the continuous process, a decanter is used. In the batch process, a separating funnel or the like can be used. When the amount is small, Can be removed.
한편, 상기 c) 단계와 d) 단계 사이에 상기 혼합 용액을 원심 분리하는 단계를 추가적으로 포함하는 경우에, 정제시간의 단축 및 정제 수율을 높이는 측면에서 장점을 가질 수 있다. On the other hand, when the step of centrifuging the mixed solution is further included between the step c) and the step d), it may be advantageous in terms of shortening the purification time and increasing the purification yield.
상기 원심분리 방법은 특별히 한정되지 않으며, 원심분리기를 사용하여 적절한 원심 분리 조건을 설정하여 수행할 수 있다. 예를 들어, 500g, 1000g, 2000g, 4000g 또는 6000g 등의 조건으로 수행할 수 있고, 원심 분리의 시간은 10 초, 20초, 30 초, 또는 1 분 내외로 수행할 수 있으며, 이러한 원심 분리를 통해서 혼합 수용액 및 유기 용매의 밀도 차이에 따라서 단시간 내에 상분리가 일어나 d) 단계에서 보다 효율적으로 유기용매의 제거가 가능하다.The centrifugation method is not particularly limited, and can be performed by setting appropriate centrifugation conditions using a centrifuge. For example, 500 g, 1000 g, 2000 g, 4000 g or 6000 g, and the centrifugation time can be 10 seconds, 20 seconds, 30 seconds, or about 1 minute, Phase separation occurs in a short time depending on the difference in density of the mixed aqueous solution and the organic solvent, and the organic solvent can be removed more efficiently in the step d).
한편, 본 발명에서의 각각의 단계 중, b) 내지 d) 단계를 순차적으로 추가 수행하게 되는 경우에 미반응 표지자의 제거율이 높아지므로, 필요에 따라 b) 및 d) 단계를 1 회 이상 수행할 수 있다.On the other hand, when the steps b) to d) are sequentially performed in the respective steps of the present invention, the removal rate of unreacted markers is increased, so that b) and d) .
또한, 필요에 따라, 본 발명에 따른 미반응 화학적 표지자의 제거 방법에 있어, 미반응 핵산을 제거하는 단계가 b) 단계 이전 또는 d) 단계 이후에 추가로 수행될 수 있다.In addition, if necessary, in the method for removing unreacted chemical markers according to the present invention, the step of removing the unreacted nucleic acid may be further performed before the step b) or after the step d).
이와 관련하여, 작용기를 갖는 핵산을 과량의 화학적 표지자와 반응시키는 경우에는, 핵산과 표지자의 반응 효율이 상당히 높으므로, 수용액 층에 남아있는 미반응의 핵산을 추가로 제거하는 단계가 거의 무의미하다. 예를 들어, 양질의 아민-변형 올리고 핵산 등을 사용하여 표지자와 반응시키는 경우에는, 핵산과 표지자의 반응 효율이 상당히 높아, 수용액 층에 남아있는 미반응의 핵산을 추가로 제거하는 단계가 거의 무의미할 정도이나, 핵산과 표지자의 반응 효율이 높지 않은 경우에는 표지화된 핵산만을 선별적으로 정제하기 위해, 상기 미반응의 표지자를 제거하는 단계 후에, 수용액 층에 남아있는 미반응의 핵산을 추가로 제거할 필요성이 있고, 본 발명에서 이러한 미반응 핵산의 제거 방법은 공지된 방식에 따라 진행될 수 있다.In this regard, when the nucleic acid having a functional group is reacted with an excessive amount of a chemical marker, the step of removing the unreacted nucleic acid remaining in the aqueous solution layer is almost meaningless since the reaction efficiency between the nucleic acid and the marker is considerably high. For example, when a high quality amine-modified oligonucleic acid or the like is used to react with a marker, the reaction efficiency between the nucleic acid and the marker is considerably high, and the step of further removing the unreacted nucleic acid remaining in the aqueous solution layer is almost meaningless In the case where the reaction efficiency between the nucleic acid and the marker is not high, in order to selectively purify only the labeled nucleic acid, the unreacted nucleic acid remaining in the aqueous solution layer is further removed And the method of removing such unreacted nucleic acid in the present invention can be carried out according to a known method.
일반적인 미반응 핵산의 제거 방법으로는, 역상 및 이온 교환과 같은 크로마토그래피법, 또는 겔 전기영동과 같은 방법이 있으며, 소수성의 표지자로 표지화된 핵산은 부분적으로 소수성을 띄게 되므로, 미반응 핵산의 친수성과는 차이가 있어, 보다 간단한 정제를 가능하게 한다. 따라서, 표지화된 핵산과 미반응 핵산은 HPLC 역상 크로마토그래피를 통해 서로 분리될 수 있으며, 일회용 역상 칼럼(Polypak, Glen Research, Inc., USA) 등을 사용하여 정제할 수 있다.Generally, unreacted nucleic acid can be removed by chromatography such as reversed phase and ion exchange, or gel electrophoresis. Since the nucleic acid labeled with a hydrophobic marker is partially hydrophobic, the hydrophilic nature of the unreacted nucleic acid And thus simpler purification is possible. Thus, the labeled nucleic acid and the unreacted nucleic acid can be separated from each other by HPLC reverse phase chromatography, and can be purified using a disposable reversed phase column (Polypak, Glen Research, Inc., USA).
도 2는 본 발명에 따른 화학적으로 표지된 핵산의 분리 정제 방법을 예시적 구성을 시간적 순서에 따라 나타낸 그림으로, 보다 상세하게는 본 발명에 따른, 수용액상의 pH 제어를 통하여 표지화된 올리고 핵산을 제조하기 위한 화학적 표지자와 핵산과의 반응으로부터 미반응 염료를 제거하는 방법을 예시적으로 나타낸 개념도이다. 2 is a cross- The present invention relates to a method of separating and purifying a chemically labeled nucleic acid according to the present invention in a temporal order, and more particularly, to a method for producing a labeled nucleic acid A method for removing unreacted dyes from a reaction between a marker and nucleic acid is exemplarily shown.
상기 도 2에 도시된 바와 같이 본 발명에 따른 핵산의 분리 정제방법은, pH 조절된 수용액을 표지화된 핵산 반응 용액에 첨가한 후, 미반응의 표지자를 유기용매로 추출하기 위해서 수용액의 2 내지 4배의 물로 포화된 부탄올을 추가적으로 첨가하여 10초 이상 볼텍스 믹서를 사용하여 교반시키고 이후에, 상부에 위치한 미반응의 표지자가 분산된 부탄올 용액을 마이크로 피펫 등의 기구를 사용하여 제거하면, 수용액층에서 고순도의 표지화된 핵산이 분산된 수용액을 얻을 수 있음을 개략적으로 나타내고 있다. As shown in FIG. 2, the method for separating and purifying nucleic acid according to the present invention comprises the steps of adding a pH-adjusted aqueous solution to a labeled nucleic acid reaction solution, and then adding 2 to 4 When butanol saturated with boiling water was additionally added, stirring was performed using a vortex mixer for 10 seconds or more, and then a butanol solution in which an unreacted marker located at the upper part was dispersed was removed by using a micropipette or the like, It is schematically shown that an aqueous solution in which a highly purified labeled nucleic acid is dispersed can be obtained.
또한, 본 발명은 상기 방법을 이용하는, 화학적으로 표지된 핵산의 분리 정제 방법용 키트를 제공할 수 있다. In addition, the present invention can provide a kit for a method for separating and purifying a chemically-labeled nucleic acid using the above method.
상기 키트의 일 구현예로서, 상기 키트는 핵산과 반응 가능한 화학적 표지자를 포함하며, 수용액을 포함하는 핵산이 투입되는 경우에, 상기 핵산과 화학적 표지자가 반응할 수 있는 제1 용기; 소정의 pH값을 가지는 산성 수용액을 포함하는 제3 용기; 및 물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기;를 포함하며, 상기 제3 용기내 산성 수용액의 pH는, 상기 제1용기내의 화학적 표지자가 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 한다. 이 경우에 상기 키트는 제1 용기에서 핵산과 화학적 표지자가 반응한 후에 이에 제3 용기내 산성수용액을 투입함으로써, pH를 조절하고 이후에 제4용기내의 유기용매를 투입하여 층분리를 진행하여 표지화된 핵산을 정제할 수 있다.In an embodiment of the kit, the kit includes a chemical label capable of reacting with a nucleic acid, and a first container in which, when a nucleic acid containing an aqueous solution is introduced, the nucleic acid and the chemical marker can react with each other; A third container containing an acidic aqueous solution having a predetermined pH value; And a fourth container containing an organic solvent containing at least a part of water (H2O), wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid, And the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker. In this case, the kit may be prepared such that after the nucleic acid and the chemical marker react in the first container, the acidic aqueous solution is added to the third container, the pH is adjusted, and then the organic solvent in the fourth container is introduced, The nucleic acid can be purified.
또 다른 일 구현예로서, 상기 키트는 핵산과 반응 가능한 화학적 표지자를 포함하는 제1 용기; 수용액을 포함하며, 상기 제1용기내 화학적 표지자와 핵산을 반응시키기 위한 제2 용기; 소정의 pH값을 가지는 산성 수용액을 포함하는 제 3 용기; 및 물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기;를 포함하며, 상기 제3 용기내 산성 수용액의 pH는, 상기 제1용기내의 화학적 표지자가 제2 용기 내에서 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 한다. 이 경우에 상기 키트는 제2 용기에서 핵산과 화학적 표지자가 반응한 후에 이에 제3 용기내 산성수용액을 투입함으로써, pH를 조절하고 이후에 제4용기내의 유기용매를 투입하여 층분리를 진행하여 표지화된 핵산을 정제할 수 있다.In another embodiment, the kit comprises a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; Wherein the pH of the acidic aqueous solution in the third container is such that the chemical markers in the first container are in contact with the nucleic acid in the second container, The pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the reaction is set to be lower than the pKa of the chemical marker. In this case, the kit may be prepared such that after the nucleic acid and the chemical marker react in the second container, the acidic aqueous solution is added to the third container, the pH is adjusted, and then the organic solvent in the fourth container is introduced, The nucleic acid can be purified.
또 다른 일 구현예로서, 상기 키트는 핵산과 반응 가능한 화학적 표지자를 포함하는 제1 용기; 수용액을 포함하며, 상기 제1용기내 화학적 표지자와 핵산을 반응시키기 위한 제2 용기; 소정의 pH값을 가지는 산성 수용액을 포함하는 제 3 용기; 및 물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기; 및 상기 화학적 표지자와 반응 가능한 핵산을 포함하는 제5 용기;를 포함하며, 상기 제3 용기내 산성 수용액의 pH는, 상기 제1용기내의 화학적 표지자가 제2 용기 내에서 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 한다. 이 경우에 상기 키트는 제1 용기내의 화학적 표지자와 제5용기내의 핵산을 제2 용기에서 반응시킨 후에 이에 제3 용기내 산성수용액을 투입함으로써, pH를 조절하고 이후에 제4용기내의 유기용매를 투입하여 층분리를 진행하여 표지화된 핵산을 정제할 수 있다.In another embodiment, the kit comprises a first container comprising a chemical marker capable of reacting with a nucleic acid; A second container for reacting the nucleic acid with a chemical marker in the first container; A third container containing an acidic aqueous solution having a predetermined pH value; And an organic solvent containing at least a part of water (H2O); Wherein the pH of the acidic aqueous solution in the third container is such that the chemical indicator in the first container reacts with the nucleic acid in the second container, And the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container is set to be lower than the pKa of the chemical marker. In this case, the kit can be prepared by reacting a chemical marker in the first container with a nucleic acid in the fifth container in a second container, and then introducing an acidic aqueous solution in the third container to adjust the pH, The labeled nucleic acid can be purified.
또한, 본 발명에서의 상기 표지화된 핵산의 분리 정제용 키트는 상기 화학적 표지자와 핵산이 반응 후, 상기 제3 용기의 산성 수용액을 혼합함에 있어, pH를 조정하기 위한 염기성 수용액을 포함하는 용기를 추가적으로 구비할 수 있다. 또한 상기 키트는 유기용매와 수용액을 분리할 수 있는 분리장치를 추가적으로 포함할 수 있고, 예시적인 분리장치로서 분별깔대기, 피펫, 원심분리기 등을 사용할 수 있다.The kit for separating and purifying the labeled nucleic acid according to the present invention may further comprise a container containing a basic aqueous solution for adjusting the pH in mixing the acidic aqueous solution of the third container with the nucleic acid after the chemical label is reacted with the nucleic acid, . In addition, the kit may further include a separation device capable of separating the organic solvent and the aqueous solution, and a separating funnel, a pipette, a centrifuge, etc. may be used as an exemplary separation device.
본 발명에 따른 표지화된 핵산의 분리 정제용 키트 앞서 상세히 설명한 표지화된 핵산의 분리 정제방법을 실제로 적용하기 위한 장치로서, 상기 제1 용기 내지 제4용기의 재질은 금속, 유리, 고무, 실리콘, 플라스틱 재질 등이 사용가능하나 이에 제한되지 않으며, 또한 이의 크기도 사용되는 유기용매 및 핵산의 함량에 따라 통상의 기술자가 적절히 변경할 수 있는 정도로서 다양한 변형이 가능하다. A kit for separating and purifying a labeled nucleic acid according to the present invention is a device for actually applying a method for separation and purification of a labeled nucleic acid as described in detail above, wherein the materials of the first to fourth containers are metal, glass, rubber, Materials and the like can be used, but the present invention is not limited thereto, and the size thereof can be variously modified in accordance with the content of the organic solvent and the nucleic acid to be used, and can be appropriately changed by a person skilled in the art.
이하, 바람직한 실시예를 들어 본 발명을 더욱 상세하게 설명한다. 그러나 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이에 의하여 제한되지 않는다는 것은 당업계의 통상의 지식을 가진 자에게 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to preferred embodiments. It will be apparent to those skilled in the art, however, that these examples are provided to further illustrate the present invention, and the scope of the present invention is not limited thereto.
<실시예 1>&Lt; Example 1 >
1) 2 ml 튜브에 아민기를 가진 변형 올리고 핵산(DNA 30 mer/ 60mer)과 형광염료 Cy 5(Cy5 NHS ester # PA 15104)를 1:10 의 몰비로 반응시키고, 상온에서 2~3 시간 유지시켰다. 1) A modified oligo nucleic acid (DNA 30 mer / 60mer) having an amine group and a fluorescent dye Cy 5 (Cy5 NHS ester # PA 15104) in a 2 ml tube were reacted at a molar ratio of 1:10 and maintained at room temperature for 2 to 3 hours .
- DMSO(dimethyl sulfoxide)에 녹인 Cy5 : 25 nmole/5.21 ul- Cy5 dissolved in dimethyl sulfoxide (DMSO): 25 nmole / 5.21 ul
- 물에 녹인 핵산(DNA 30 mer/ 60mer) : 5 nmole/8.17 ul- Nucleic acid (DNA 30 mer / 60 mer) dissolved in water: 5 nmole / 8.17 ul
- 0.2M SB(Sodium Borate) 버퍼 (pH 8.5) : 20 ul- 0.2 M SB (Sodium Borate) buffer (pH 8.5): 20 ul
- 물 : 16.62 ul- Water: 16.62 ul
- 전체 반응 용액 부피 : 50 ul- total reaction solution volume: 50 ul
상기 변형 올리고 핵산(DNA 30 mer, 60mer)의 서열은 하기 표 1과 같다.The sequence of the modified oligonucleotide (DNA 30 mer, 60mer) is shown in Table 1 below.
[표 1][Table 1]
Figure PCTKR2018010153-appb-I000001
Figure PCTKR2018010153-appb-I000001
2) HCl 용액을 일정량 첨가하여 pH값을 3.0으로 맞춰진 수용액 500 ul을 제조한 후 1의 반응을 보낸 용액을 첨가한다. 2) Add a certain amount of HCl solution to make 500 μl of the aqueous solution adjusted to pH 3.0, and then add the solution of reaction 1.
3) 2 에서 준비된 용액에 물로 포화된 n-부탄올 1.5 ml 를 첨가하고, 볼텍스 믹서(vortex mixer)로 약 10초간 섞어주고, 4000 g로 약 10초간 원심 분리하였다.3) To the solution prepared in 2 was added 1.5 ml of n-butanol saturated with water, mixed with a vortex mixer for about 10 seconds, and centrifuged at 4000 g for about 10 seconds.
4) 3 에 의해 나뉘어진 용액 층 중 상층액인 유기 용매층을 피펫으로 제거하였다.4) The organic solvent layer as the upper layer of the solution layer divided by 3 was removed by pipette.
5) 2~4 의 과정을 2 회 더 반복하였고, 상기 2~4 의 과정을 모두 진행하는 데 걸린 시간은 3분 이내였다.5) The procedures 2 to 4 were repeated two more times, and the time taken to complete the above steps 2 to 4 was within 3 minutes.
<실시예 2>&Lt; Example 2 >
형광염료로서 Cy 5을 Cy 3(GE healthcare #PA 13106)으로 변경하고, 단계 2에서의 수용액을 pH=2로 맞춘 것을 제외하고는 실시예 1 과 동일한 방법으로 수행하였다. The procedure of Example 1 was repeated except that Cy 5 was changed to Cy 3 (GE healthcare #PA 13106) as a fluorescent dye and the aqueous solution in Step 2 was adjusted to pH = 2.
<실시예 3>&Lt; Example 3 >
형광염료로서 Cy 5을 Alexa 488(Alexa Fluor 488 NHS Ester (Succinimidyl Ester) Thermo Fisher scientific A20000) 으로 변경하고, 단계 2의 수용액을 pH=2로 맞춘 것을 제외하고는 실시예 1 과 동일한 방법으로 수행하였다.Except that Cy 5 was changed to Alexa 488 (Alexa Fluor 488 NHS Ester (Succinimidyl Ester) Thermo Fisher scientific A 20000) as a fluorescent dye, and the aqueous solution of step 2 was adjusted to pH = 2 .
<실시예 4><Example 4>
형광염료로서 Cy 5을 Cy 3B(GE healthcare #PA 63100)으로 변경하고, 단계 2의 수용액을 pH=2로 맞춘 것을 제외하고는 실시예 1 과 동일한 방법으로 수행하였다.The procedure of Example 1 was repeated except that Cy 5 was changed to Cy 3B (GE healthcare #PA 63100) as a fluorescent dye and the aqueous solution of Step 2 was adjusted to pH = 2.
<비교예 1>&Lt; Comparative Example 1 &
1) 2ml 튜브에 아민기를 가진 변형 올리고 핵산(DNA 30 mer/ 60mer)과 형광염료 Cy 5 를 1:10 의 반응비로 반응시키고, 상온에서 2~3 시간 유지시켰다.1) A modified oligo nucleic acid (DNA 30 mer / 60mer) having an amine group in a 2 ml tube was reacted with a fluorescent dye Cy 5 at a reaction ratio of 1:10 and maintained at room temperature for 2 to 3 hours.
- DMSO(dimethyl sulfoxide)에 녹인 Cy5 : 25 nmole/5.21 ul- Cy5 dissolved in dimethyl sulfoxide (DMSO): 25 nmole / 5.21 ul
- 물에 녹인 핵산(DNA 30 mer, 60mer) : 5nmole/8.17 ul- Nucleic acid (DNA 30 mer, 60mer) dissolved in water: 5 nmole / 8.17 ul
- 0.2M SB(Sodium Borate) 버퍼 (pH 8.5) : 20 ul- 0.2 M SB (Sodium Borate) buffer (pH 8.5): 20 ul
- 물 : 16.62 ul- Water: 16.62 ul
- 전체 반응 용액 부피 : 50 ul- total reaction solution volume: 50 ul
2) NaOH 용액을 일정량 첨가하여 pH값을 8.5로 맞춰진 수용액 500 ul을 제조한 후 1의 반응을 보낸 용액을 첨가한다.2) Add a certain amount of NaOH solution to make 500 μl of an aqueous solution having a pH value of 8.5, and then add the solution to which the reaction 1 has been passed.
3) 2 에서 준비된 용액에 물로 포화된 n-부탄올 1.5 ml 를 첨가하고, 볼텍스 믹서(vortex mixer)로 약 10초간 섞어주고, 4000 g 로 약 10초간 원심 분리하였다.3) To the solution prepared in 2 was added 1.5 ml of n-butanol saturated with water, mixed with a vortex mixer for about 10 seconds, and centrifuged at 4000 g for about 10 seconds.
4) 3 에 의해 나뉘어진 용액 층 중 상층액인 유기 용매층을 피펫으로 제거하였다.4) The organic solvent layer as the upper layer of the solution layer divided by 3 was removed by pipette.
5) 2~4 의 과정을 2 회 더 반복하였고, 상기 2~4 의 과정을 모두 진행하는 데 걸린 시간은 3분 이내였다.5) The procedures 2 to 4 were repeated two more times, and the time taken to complete the above steps 2 to 4 was within 3 minutes.
<비교예 2>&Lt; Comparative Example 2 &
형광염료로서 Cy 5을 Cy 3 으로 변경하고, 단계 2의 수용액을 pH=8.5로 맞춘 것을 제외하고는 실시예 1 과 동일한 방법으로 수행하였다.The procedure of Example 1 was repeated except that Cy 5 was changed to Cy 3 as the fluorescent dye and the aqueous solution of Step 2 was adjusted to pH = 8.5.
<비교예 3>&Lt; Comparative Example 3 &
형광염료로서 Cy 5을 Alexa 488 으로 변경하고, 단계 2의 수용액을 pH=8.5로 맞춘 것을 제외하고는 실시예 1 과 동일한 방법으로 수행하였다.The procedure of Example 1 was repeated except that Cy 5 was changed to Alexa 488 as the fluorescent dye and the aqueous solution of Step 2 was adjusted to pH = 8.5.
도 3은 본 발명에 따른 실시예 (실시예1 ,2, 3) 및 비교예 (비교예1 ,2, 3)에 따른 일정 PH 조건하에서 하부의 수용액층과 상부의 유기용매층으로 핵산과 형광 염료가 분배된 정도를 나타내는 실제 사진으로서, 각각의 사진의 형광염료는 (A) Cy 5 (좌측은 비교예1, 우측은 실시예1), (B) Cy 3 (좌측은 비교예2, 우측은 실시예2), (C) Alexa 488 (좌측은 비교예3, 우측은 실시예3),를 나타내고 있다. Fig. 3 is a graph showing the relationship between the amount of the nucleic acid and the fluorescence (fluorescence) of the organic solvent layer on the lower aqueous solution layer and the upper organic solvent layer under constant PH conditions according to the examples (Examples 1, 2 and 3) (A) Cy5 (Comparative Example 1 on the left, Example 1 on the right), (B) Cy3 (Comparative Example 2 on the left, Comparative Example 2 on the right), Cy3 (Example 2), (C) Alexa 488 (Comparative Example 3 on the left, and Example 3 on the right).
상기 도 3에 따르면, pH=8.5와 pH=3, 2 조건하에서 하부의 수용액층과 상부의 유기용매층으로 핵산과 형광 염료가 분배된 정도를 나타내는 실제 사진을 통해서 pH 값에 따라서 유기용매 층으로 형광염료가 분배된 정도를 가시적으로 확인할 수 있다. According to FIG. 3, according to actual photographs showing the distribution of nucleic acid and fluorescent dye to the lower aqueous solution layer and the upper organic solvent layer under pH = 8.5 and pH = 3 and 2 conditions, The degree of distribution of the fluorescent dye can be visually confirmed.
보다 구체적으로, 실시예 1의 결과, 도 3(A)에서와 같이 pH = 8.5 조건에서는 Cy 5가 하부의 수용액 상에서 음이온 상태로 용해되어있는 것을 관찰할 수 있으나, pH = 3 조건에서 수용액 상의 Cy 5가 양성자와 결합하여 중성상태로 변화하면서 상부의 유기용매 층에서 추출되어 녹아있는 것을 확인할 수 있다. 이때, 하부에 존재하는 형광은 형광염료로 표지화된 핵산 또는 미제거된 미반응 형광 염료일 수 있다. 이러한 양상은 실시예 2의 결과에 따른 도 3(B) Cy 3에서 나타나고, 실시예 3의 결과에서의 도 3(C) Alexa 488에서 동일하게 나타난다.More specifically, as a result of Example 1, it can be observed that Cy5 is dissolved in an anionic state in the lower aqueous solution under the condition of pH = 8.5 as shown in Fig. 3 (A) 5 is converted to a neutral state in combination with the proton, and is extracted and dissolved in the upper organic solvent layer. At this time, the fluorescence present in the lower part may be a nucleic acid labeled with a fluorescent dye or an unreacted unreacted fluorescent dye. This pattern appears in Fig. 3 (B) Cy 3 according to the results of Example 2 and is the same in Fig. 3 (C) Alexa 488 in the result of Example 3.
도 4의 A는 본 발명에서의 비교예 1에 따른, pH=8.5 조건하에서 유기용매를 처리하여 수용액과 유기용매에 분배되어 분리된 후 수용액 상에 잔존하는 형광염료(Cy 5)와 핵산의 농도를 유기용매를 처리한 각 단계별로 도시한 그래프이고, 도 4의 B는 본 발명에 따른 실시예 1에 따른 pH=3 조건하에서 유기용매를 처리하여 수용액과 유기용매에 분배되어 분리된 후 수용액 상에 잔존하는 형광염료(Cy 5)와 핵산의 농도를 유기용매를 처리한 각 단계별로 도시한 그래프이다.Fig. 4A is a graph showing the relationship between the concentration of the fluorescent dye (Cy5) remaining in the aqueous solution and the concentration of the nucleic acid after being separated into an aqueous solution and an organic solvent after being treated with an organic solvent under the condition of pH = 8.5 according to Comparative Example 1 of the present invention FIG. 4 (B) is a graph showing the results obtained by treating an organic solvent under pH = 3 according to Example 1 according to the present invention, dividing it into an aqueous solution and an organic solvent, (Cy 5) and the concentration of the nucleic acid in each step of treating the organic solvent.
상기 도 4에 따른 실시예 1에 결과, Cy 5 형광염료를 pH = 3 조건에서 본원 발명의 정제 방법으로 수회 반복 했을 경우, 수용액 상에 Cy 5와 DNA 농도가 거의 비슷하게 존재하는 것으로 나타나고 있고, 이는 Cy 5와 DNA가 일대일 반응을 통하여 얻어진 Cy 5로 표지화된 DNA로부터 얻어진 농도이므로, 수용액 상에 미반응의 형광염료인 Cy 5가 거의 제거되었다고 볼 수 있다. As a result of Example 1 according to FIG. 4, when the Cy 5 fluorescent dye was repeated several times by the purification method of the present invention under the condition of pH = 3, Cy 5 and DNA concentrations were found to be almost similar in the aqueous solution, Since the concentration of Cy5 and DNA is obtained from Cy5-labeled DNA obtained through a one-to-one reaction, Cy5, an unreacted fluorescent dye, is almost completely removed on the aqueous solution.
이에 반하여 비교예 1에 따른 pH = 8.5 조건 하에서 분리 정제하는 경우에 수용액상에 음이온 상태의 Cy 5가 지배적으로 존재하여, 미량의 중성상태의 Cy 5 만이 유기 용매 층으로 분배되어 수용액 상에 잔존하는 농도가 정제 횟수를 거듭하더라도 Cy 5가 DNA보다 훨씬 높은 농도로 존재하는 것으로 나타나며, 이는 미반응의 Cy 5가 수용액 상에 남아있는 것으로 보여짐에 따라서, 본 발명에 따른 pH제어를 통한 정제 방법을 진행하는 경우에 DNA을 단시간내에 고효율로 분리 정제가 가능함을 나타낸다.On the other hand, in the case of separation and purification under the pH = 8.5 condition according to Comparative Example 1, Cy5 in an anionic state predominantly exists on the aqueous phase, and only Cy5 in a small amount of neutral state is distributed in the organic solvent layer to remain in the aqueous solution Cy 5 is present at a much higher concentration than DNA even when the concentration is repeated over a number of times. Since the unreacted Cy 5 appears to remain in the aqueous solution, the purification method through the pH control according to the present invention proceeds Indicating that DNA can be separated and purified with high efficiency within a short time.
도 5는 에탄올 재결정법과 본원발명의 분리 정제 방법을 통해서 수득된 수용액상의 혼합물을 액체크로마토그래피(HPCL)를 통하여 분리 정제한 결과를 나타낸 그래프로서, 보다 상세하게는 도 5의 상부 그래프는 종래 기술에 따른 에탄올 재결정법에 따라 분리 정제된 수용액상의 혼합물(Cy 5와 DNA)을 각각 액체크로마토그래피(HPLC)를 이용하여 분리한 결과를 도시하였고, 도 5의 하부 그래프에서는 본 발명에 따른 실시예1에 따른 pH 제어를 이용한 용매 추출법에 따른 결과를 도시하였다. FIG. 5 is a graph showing the result of separation and purification of a mixture in an aqueous solution obtained by the ethanol recrystallization method and the separation and purification method of the present invention through liquid chromatography (HPCL). More specifically, the upper graph of FIG. (Cy 5 and DNA) in aqueous solution separated and purified according to the ethanol recrystallization method according to the present invention were separated by liquid chromatography (HPLC), respectively. In the lower graph of FIG. 5, And the result of solvent extraction using pH control according to the present invention.
도 5에 따르면 상기 에탄올 재결정 법에 의해 정제된 혼합물의 경우 미반응의 형광염료인 Cy 5가 10~13분 사이에서 검출된 반면, 본원 발명인 pH 조절을 이용한 추출법의 경우에는 미반응의 형광염료 Cy 5가 검출되지 않았으며, 이를 통해서 기존의 에탄올 재결정법에 비해 본원발명의 분리 정제방법이 고효율의 분리 정제 방법임을 나타낸다.According to FIG. 5, the unreacted fluorescent dye Cy 5 was detected between 10 and 13 minutes in the case of the mixture purified by the ethanol recrystallization method, whereas in the case of the extraction method using pH control according to the present invention, unreacted fluorescent dye Cy 5 was not detected, indicating that the separation and purification method of the present invention is a highly efficient separation and purification method as compared with the conventional ethanol recrystallization method.
도 6은 종래기술에 따른 에탄올 재결정법 및 본원발명에 의해 분리정제된 표지화된 핵산의 형광성능을 테스트한 결과를 나타내었다.FIG. 6 shows the results of testing the fluorescent performance of the ethanol recrystallization method according to the prior art and the labeled nucleic acid isolated and purified according to the present invention.
보다 구체적으로, 도 6의 A는 형광염료인 Cy 5로 표지화된 ssDNA를 상보적 사슬과 함께 소성한 후, 공초점 현미경(confocal microscopy)를 통해서 관찰한 결과로서, 종래 기술에 따른 에탄올 재결정법(도 6의 상부좌측 그래프)과 본 발명에 따른 실시예1에 따른 pH 제어를 이용한 용매 추출법(도 6의 상부우측 그래프)에 의해 분리 정제된 수용액상의 혼합물(Cy 5와 dsDNA)을 공초점 현미경(confocal microscopy)을 통하여 얻은 이미지를 도시하였으며, 이때, 에탄올 재결정법과 본원발명에 의해 정제된 두 샘플에서 나타나는 형광 성능이 차이가 없는 것을 알 수 있고, 따라서 본 발명에 따른 정제방법이 유용하게 사용될 수 있음을 나타내고 있다.More specifically, FIG. 6A shows the ssDNA labeled with a fluorescent dye, Cy5, together with a complementary chain, followed by confocal microscopy. As a result, 6) and the mixture (Cy5 and dsDNA) in the aqueous solution separated and purified by the solvent extraction method using the pH control according to Example 1 according to the present invention (upper right graph in FIG. 6) were examined with a confocal microscope confocal microscopy. It can be seen that there is no difference in fluorescence performance between the ethanol recrystallization method and the two samples purified by the present invention, and thus the purification method according to the present invention can be usefully used. .
한편, 도 6의 B는 종래 기술에 따른 에탄올 재결정법(도 6의 하부좌측 그래프)과 본 발명에 따른 실시예1에 따른 pH 제어를 이용한 용매 추출법(도 6의 하부우측 그래프)에 의해 분리 정제된 수용액상의 혼합물(Cy 5와 dsDNA)의 이미지의 픽셀당 광자수 및 최대 광자수를 나타낸 그래프를 도시하였으며, 상기 도 6(B)에서 픽셀당 광자 수 및 최대 광자 수를 측정한 결과 에탄올 재결정법과 본원 발명에 의해 정제한 두 샘플에서 차이가 없는 것을 확인할 수 있고 이를 통해서 본원 발명을 통해 분리 정제된 표지화된 핵산의 형광 성능이 유지되어 다양한 방식의 표지에 응용 가능함을 알 수 있다.FIG. 6B is a graph showing the results of separation and purification by the ethanol recrystallization method (lower left graph in FIG. 6) and the solvent extraction method using pH control according to Example 1 (lower right graph in FIG. 6) (Cy 5 and dsDNA) in the aqueous solution, the number of photons per pixel and the maximum number of photons were measured. In FIG. 6 (B), the number of photons per pixel and the maximum number of photons were measured. It can be confirmed that there is no difference in the two samples purified by the present invention. Thus, it can be seen that the fluorescence performance of the labeled nucleic acid isolated and purified through the present invention can be maintained and applied to various types of labels.
실시예 4의 결과, 도 7(A)는 pH = 1.8~9.0 조건에서 Cy3B 형광염료의 분리 정제 후 자외선/가시광선 분광법을 통하여 수용액상에 잔존하는 Cy3B의 흡광도를 측정한 결과, pH 값이 낮아 질수록 미반응의 Cy3B 형광염료의 분리도가 증가하여, Cy3B의 흡광도가 감소하는 것으로 나타난다. 또한, 도 7(B)에서 pH = 2.0 조건에서 본원 발명의 Cy3B 형광염료의 분리 정제율을 나타낸 그래프이다.As a result of Example 4, Fig. 7 (A) shows the result of measuring the absorbance of Cy3B remaining in the aqueous solution through ultraviolet / visible light spectroscopy after separation and purification of Cy3B fluorescent dye at pH = 1.8 to 9.0. The higher the degree of separation of the unreacted Cy3B fluorescent dye, the lower the absorbance of Cy3B. 7B is a graph showing the separation and purification rate of the Cy3B fluorescent dye of the present invention under the condition of pH = 2.0.
또한, 도 8에서는, ssDNA를 본 발명에 따른 조건(pH 3.0)에서 정제한 샘플(A) 과 ssDNA를 pH 1.6, 38 ℃ 조건에서 2시간 동안 처리한 Depurinated sample(C)을 비교하였을 때, 본 발명에 따른 정제법으로 pH 3.0에서 정제된 샘플에서는 일반적으로 핵산에 형광염료를 표지하는 조건인 pH 8.5에서 보관한 샘플(B)과 마찬가지로 구아닌(Guanine)과 아데닌(Adenine)이 검출되지 않은 것을 보여주고 있어, 본 발명에 따른 핵산의 분리 정제법을 이용하는 경우에 정제된 핵산이 본 발명에 따른 정제과정에서의 반응조건 등에 의해 파괴되거나 또는 형광표지된 부분이 이탈되지 않는 것으로 나타나고 있어, 본 발명의 기술적 응용 가능성이 넓음을 확인할 수 있다. In FIG. 8, when the samples (A) purified from the ssDNA under the conditions (pH 3.0) according to the present invention and the depurinated sample (C) treated with ssDNA at pH 1.6 and 38 ° C for 2 hours were compared, In the sample purified at pH 3.0 by the purification method according to the invention, guanine and adenine were not detected in the same manner as the sample (B) stored at pH 8.5, which is a condition for labeling nucleic acid with a fluorescent dye, In the case of using the nucleic acid separation and purification method according to the present invention, it is shown that the purified nucleic acid is destroyed by the reaction conditions or the like in the purification process according to the present invention, or the fluorescently labeled portion is not released, It is confirmed that the possibility of technical application is wide.
이상, 본 발명의 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적인 기술은 단지 바람직한 실시 형태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 맹백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.Having described specific portions of the present invention in detail, those skilled in the art will appreciate that these specific descriptions are only for the preferred embodiments and that the scope of the present invention is not limited thereto Will be blind. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.
본 발명에 따른 pH 제어에 의한 화학적으로 표지된 올리고 핵산의 간편하고 효율적인 분리정제법은 표지자의 종류에 상관없이 다양한 종류의 미반응 표지자를 고효율로 용이하게, 표지화된 핵산을 분리 정제할 수 있으며, 이를 이용한 키트의 제조가 용이하여 산업상 이용가능성이 높다.The simple and efficient separation and purification method of chemically labeled oligonucleic acid by pH control according to the present invention can separate and purify the labeled nucleic acid easily and efficiently with various kinds of unreacted markers regardless of the type of the marker, It is easy to manufacture a kit using the same, which is highly likely to be used in industry.

Claims (17)

  1. a) 화학적 표지자 및 상기 화학적 표지자와 반응가능한 핵산을 수용액상에서 반응시켜 반응용액을 준비하는 단계;a) preparing a reaction solution by reacting a chemical marker and a nucleic acid capable of reacting with the chemical marker in an aqueous solution;
    b) 상기 반응용액의 pH를 미리 설정된 범위내로 조절하는 단계;b) adjusting the pH of the reaction solution to within a predetermined range;
    c) 상기 pH가 조절된 반응용액에 수용액층 및 유기용매층으로 분리되는 유기 용매를 첨가하고 교반하여 혼합 용액을 제조하는 단계; 및c) adding an organic solvent separated into the aqueous solution layer and the organic solvent layer to the pH-adjusted reaction solution, and stirring to prepare a mixed solution; And
    d) 상기 유기 용매의 적어도 일부를 제거하는 단계;를 포함하는 화학적으로 표지된 핵산의 분리 정제 방법.and d) removing at least a portion of the organic solvent.
  2. 제 1 항에 있어서, The method according to claim 1,
    상기 c) 단계에서 첨가되는 유기 용매는 물(H2O)을 포함하는 것을 특징으로 하는 화학적으로 표지된 핵산의 분리 정제 방법.Wherein the organic solvent added in step c) comprises water (H2O).
  3. 제2항에 있어서,3. The method of claim 2,
    상기 유기 용매는 물(H2O)이 포화된 상태의 유기용매를 사용하는 것을 특징으로 하는 화학적으로 표지된 핵산의 분리 정제 방법.Wherein the organic solvent is an organic solvent in which water (H2O) is saturated.
  4. 제 1 항에 있어서, The method according to claim 1,
    상기 b) 단계에서, 미리 설정된 반응용액의 pH는 화학적 표지자의 pKa보다 낮은 범위인 것을 특징으로 화학적으로 표지된 핵산의 분리 정제 방법.Wherein the pH of the predetermined reaction solution is lower than the pKa of the chemical marker in the step b).
  5. 제 4 항에 있어서, 5. The method of claim 4,
    상기 b) 단계는 화학적 표지자의 pKa보다 낮은 pH로 맞춰진 수용액과 상기 반응용액을 혼합함으로써, 혼합된 반응 용액의 pH를 미리 설정된 범위내로 조절하는 것을 특징으로 하는 화학적으로 표지된 핵산의 분리 정제 방법.Wherein the step b) comprises adjusting the pH of the mixed reaction solution to a predetermined range by mixing the reaction solution with an aqueous solution adjusted to a pH lower than the pKa of the chemical marker.
  6. 제 1 항에 있어서, The method according to claim 1,
    추가로 e) 상기 b) 내지 d) 단계를 1 회 이상 수행하는 단계;를 포함하는 화학적으로 표지된 핵산의 분리 정제 방법.And e) performing the steps b) to d) one or more times.
  7. 제 1 항에 있어서, The method according to claim 1,
    상기 화학적 표지자는 소수성 형광염료 또는 친수성 형광염료인 것을 특징으로 하는 화학적으로 표지된 핵산의 분리 정제 방법.Wherein the chemical marker is a hydrophobic fluorescent dye or a hydrophilic fluorescent dye.
  8. 제 1 항에 있어서, The method according to claim 1,
    상기 핵산이 올리고 핵산인 것을 특징으로 하는 표지화된 핵산의 분리 정제 방법.Wherein the nucleic acid is an oligonucleic acid.
  9. 제 1 항에 있어서, The method according to claim 1,
    상기 화학적 표지자가 Alexa 488, Cy 5, ATTO 633, Cy 3, Cy 3B, ATTO 550, ATTO 390, ATTO 647N, Rhodamine 6G, Nile red 중에서 선택되는 적어도 하나 이상인 것을 특징으로 하는 표지화된 핵산의 분리 정제 방법.Wherein the chemical marker is at least one selected from Alexa 488, Cy 5, ATTO 633, Cy 3, Cy 3B, ATTO 550, ATTO 390, ATTO 647N, Rhodamine 6G and Nile red. .
  10. 제 1 항에 있어서, The method according to claim 1,
    상기 유기 용매가 log P 값이 0.6 내지 4.0 인 유기 용매인 것을 특징으로 하는, 표지화된 핵산의 분리 정제방법.Wherein the organic solvent is an organic solvent having a log P value of 0.6 to 4.0.
  11. 제 1 항에 있어서,The method according to claim 1,
    상기 유기 용매가 탄소수 3 내지 8 의 알코올, 탄소수 3 내지 8의 에테르, 클로로포름, 탄소수 2 내지 6의 알킬 아세테이트, 탄소수 6 내지 12의 방향족 탄화수소, 탄소수 5 내지 14의 선형 또는 분지형 알칸, 탄소수 5 내지 14의 시클로알칸, 탄소수 5 내지 12의 선형 또는 분지형 알킬기 및 탄소수 5 내지 12의 시클로알킬기를 갖는 탄화수소, 1,1,1-트리클로로에탄 중에서 선택되는 1종 또는 이들의 혼합액인 것을 특징으로 하는 표지화된 핵산의 분리 정제 방법.Wherein the organic solvent is selected from the group consisting of alcohols having 3 to 8 carbon atoms, ether having 3 to 8 carbon atoms, chloroform, alkyl acetates having 2 to 6 carbon atoms, aromatic hydrocarbons having 6 to 12 carbon atoms, linear or branched alkanes having 5 to 14 carbon atoms, A cycloalkane having 1 to 14 carbon atoms, a linear or branched alkyl group having 5 to 12 carbon atoms, a hydrocarbon having a cycloalkyl group having 5 to 12 carbon atoms, or 1,1,1-trichloroethane, or a mixture thereof A method for separating and purifying a labeled nucleic acid.
  12. 제 1 항에 있어서,The method according to claim 1,
    상기 c) 단계와 d) 단계 사이에 상기 혼합 용액을 원심 분리하는 단계를 포함하는 것을 특징으로 하는 화학적으로 표지된 핵산의 분리 정제 방법.And centrifuging the mixed solution between step c) and step d). &Lt; RTI ID = 0.0 &gt; 15. &lt; / RTI &gt;
  13. 핵산과 반응 가능한 화학적 표지자를 포함하며, 수용액을 포함하는 핵산이 투입되는 경우에, 상기 핵산과 화학적 표지자가 반응할 수 있는 제1 용기;A first container containing a chemical marker capable of reacting with a nucleic acid and capable of reacting with the nucleic acid and the chemical marker when a nucleic acid containing an aqueous solution is introduced;
    소정의 pH값을 가지는 산성 수용액을 포함하는 제3 용기; 및A third container containing an acidic aqueous solution having a predetermined pH value; And
    물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기;를 포함하며,And a fourth container containing an organic solvent which at least partially contains water (H2O)
    상기 제3 용기내 산성 수용액의 pH는, The pH of the acidic aqueous solution in the third vessel may be,
    상기 제1용기내의 화학적 표지자가 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트.Characterized in that the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the chemical marker in the first container reacts with the nucleic acid is set to be lower than the pKa of the chemical marker Kit for separation and purification.
  14. 핵산과 반응 가능한 화학적 표지자를 포함하는 제1 용기; A first container comprising a chemical marker capable of reacting with a nucleic acid;
    수용액을 포함하며, 상기 제1용기내 화학적 표지자와 핵산을 반응시키기 위한 제2 용기;A second container for reacting the nucleic acid with a chemical marker in the first container;
    소정의 pH값을 가지는 산성 수용액을 포함하는 제 3 용기; 및A third container containing an acidic aqueous solution having a predetermined pH value; And
    물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기;를 포함하며,And a fourth container containing an organic solvent which at least partially contains water (H2O)
    상기 제3 용기내 산성 수용액의 pH는, The pH of the acidic aqueous solution in the third vessel may be,
    상기 제1용기내의 화학적 표지자가 제2 용기 내에서 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트.Characterized in that the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the chemical marker in the first container reacts with the nucleic acid in the second container is set to be lower than the pKa of the chemical marker A kit for separating and purifying a labeled nucleic acid.
  15. 핵산과 반응 가능한 화학적 표지자를 포함하는 제1 용기; A first container comprising a chemical marker capable of reacting with a nucleic acid;
    수용액을 포함하며, 상기 제1용기내 화학적 표지자와 핵산을 반응시키기 위한 제2 용기;A second container for reacting the nucleic acid with a chemical marker in the first container;
    소정의 pH값을 가지는 산성 수용액을 포함하는 제 3 용기; 및A third container containing an acidic aqueous solution having a predetermined pH value; And
    물(H2O)을 적어도 일부 포함하고 있는 유기용매를 포함하는 제4 용기; 및A fourth container comprising an organic solvent at least partially containing water (H2O); And
    상기 화학적 표지자와 반응 가능한 핵산을 포함하는 제5 용기;를 포함하며,And a fifth container containing a nucleic acid capable of reacting with the chemical marker,
    상기 제3 용기내 산성 수용액의 pH는, The pH of the acidic aqueous solution in the third vessel may be,
    상기 제1용기내의 화학적 표지자가 제2 용기 내에서 핵산과 반응 한 후, 상기 제3 용기의 산성 수용액을 혼합함으로써 얻어지는 혼합용액의 pH가 상기 화학적 표지자의 pKa 보다 낮은 범위가 되도록 설정되는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트.Characterized in that the pH of the mixed solution obtained by mixing the acidic aqueous solution of the third container after the chemical marker in the first container reacts with the nucleic acid in the second container is set to be lower than the pKa of the chemical marker A kit for separating and purifying a labeled nucleic acid.
  16. 제 13 항 내지 제 15 항 중 어느 한 항에 있어서,16. The method according to any one of claims 13 to 15,
    상기 표지화된 핵산의 분리 정제용 키트는 상기 화학적 표지자와 핵산이 반응 후, 상기 제3 용기의 산성 수용액을 혼합함에 있어, pH를 조정하기 위한 염기성 수용액을 포함하는 용기를 추가적으로 구비하는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트.Wherein the kit for separation and purification of the labeled nucleic acid further comprises a container containing a basic aqueous solution for adjusting the pH in mixing the acidic aqueous solution of the third container after the chemical marker and the nucleic acid are reacted A kit for the separation and purification of labeled nucleic acids.
  17. 제 13 항 내지 제 15 항 중 어느 한 항에 있어서,16. The method according to any one of claims 13 to 15,
    상기 표지화된 핵산의 분리 정제용 키트는 유기용매와 수용액을 분리할 수 있는 분리장치를 추가적으로 포함하는 것을 특징으로 하는 표지화된 핵산의 분리 정제용 키트.Wherein the kit for separation and purification of the labeled nucleic acid further comprises a separation device capable of separating the organic solvent and the aqueous solution.
PCT/KR2018/010153 2017-09-08 2018-08-31 Method for simply and efficiently isolating and purifying chemically labeled oligonucleotides by means of ph control WO2019050222A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170114875A KR20190028009A (en) 2017-09-08 2017-09-08 Facile and Efficient Purification Method for chemically labeled Oligonucleotide by pH-Control
KR10-2017-0114875 2017-09-08

Publications (1)

Publication Number Publication Date
WO2019050222A1 true WO2019050222A1 (en) 2019-03-14

Family

ID=65634891

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/010153 WO2019050222A1 (en) 2017-09-08 2018-08-31 Method for simply and efficiently isolating and purifying chemically labeled oligonucleotides by means of ph control

Country Status (2)

Country Link
KR (1) KR20190028009A (en)
WO (1) WO2019050222A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286725A (en) * 2022-08-31 2022-11-04 山东万邦赛诺康生化制药股份有限公司 Preparation method of high-purity low-molecular-weight heparin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095626A1 (en) * 2003-09-03 2005-05-05 Hiroyuki Komazawa Method for separation and purification method of nucleic acid
KR20130035194A (en) * 2011-09-29 2013-04-08 서울대학교산학협력단 Convenient and efficient purification method for chemically labeled nucleic acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414136B1 (en) 1999-10-06 2002-07-02 Prolinx, Inc. Removal of dye-labeled dideoxy terminators from DNA sequencing reactions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095626A1 (en) * 2003-09-03 2005-05-05 Hiroyuki Komazawa Method for separation and purification method of nucleic acid
KR20130035194A (en) * 2011-09-29 2013-04-08 서울대학교산학협력단 Convenient and efficient purification method for chemically labeled nucleic acids

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Amine-reactive Probes", MOLECULAR PROBES, 25 February 2002 (2002-02-25), pages 1 - 5, XP055580762 *
KOLMAKOV, K. ET AL.: "Polar Red-emitting Rhodamine Dyes with Reactive Groups: Synthesis, Photophysical Properties, and Two-color STED Nanoscopy Applications", CHEM. EUR. J., vol. 20, no. 1, 2014, pages 146 - 157, XP055314527, DOI: doi:10.1002/chem.201303433 *
SIGMA-ALDRICH: "Superior Fluorescent Products", BIOFILES, vol. 6, no. 3, 2011, pages 1 - 32, XP055462214 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286725A (en) * 2022-08-31 2022-11-04 山东万邦赛诺康生化制药股份有限公司 Preparation method of high-purity low-molecular-weight heparin

Also Published As

Publication number Publication date
KR20190028009A (en) 2019-03-18

Similar Documents

Publication Publication Date Title
US9938573B2 (en) Methods and kits for nucleic acid sequencing
US5614386A (en) Alternative dye-labeled primers for automated DNA sequencing
JP4140976B2 (en) 4,7-dichlororhodamine dye
JP4554224B2 (en) 4,7-dichlorofluorescein dye as a molecular probe
US20050084870A1 (en) 4,7-dichlorofluorescein dyes as molecular probes
AU699939B2 (en) Alternative dye-labeled primers, ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis and homogeneous amplification/detection assays
JP2002535616A (en) Microfabricated capillary electrophoresis chip and method for simultaneous detection of multiple redox labels
CN105936940B (en) Nucleic acid sequence for detecting deafness gene and application thereof
WO2017074094A1 (en) A method for prenatal diagnosis using digital pcr.
WO2019050222A1 (en) Method for simply and efficiently isolating and purifying chemically labeled oligonucleotides by means of ph control
WO2018151339A1 (en) Method for detecting target gene, using dcas9/grna complex and fluorescence marker
CA2689537C (en) Epigenetic methods
WO2013122319A1 (en) Method for detecting target gene or mutation thereof using ligase reaction and nicking enzyme amplification reaction
CN104725453B (en) Fluorescence-labeled nucleotides of azo-based connection unit and application thereof
WO2019132581A1 (en) Composition for diagnosing cancer such as breast cancer and ovarian cancer, and use thereof
WO2018048194A1 (en) Composition and method for improving sensitivity and specificity of detection of nucleic acids using dcas9 protein and grna binding to target nucleic acid sequence
WO2018186682A1 (en) Biosensor substrate, method for producing same, and biosensor comprising same
WO2011142646A2 (en) Method for detecting hpv (human papilloma virus) and genotype thereof
WO2020133590A1 (en) Method and test kit for quickly preparing monomolecular optical spectrum labeling library
EP3368690A1 (en) A method for prenatal diagnosis using digital pcr.
WO2013105679A1 (en) Apparatus for amplifying nucleic acids comprising primer, method for manufacturing same, and method for amplifying nucleic acids using apparatus comprising primer for amplifying nucleic acids
WO2013048163A2 (en) Convenient and efficient purification method for chemically labeled nucleic acids
WO2023204667A1 (en) Microparticle probe for single nucleotide polymorphism analysis
WO2017051939A1 (en) Method for extracting and amplifying nucleic acid using magnetic particles
WO2024075941A1 (en) Super absorbent polymer-based surface fixation technology for extracellular vesicles or cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18855074

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18855074

Country of ref document: EP

Kind code of ref document: A1